{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:31:12Z","timestamp":1794324672941,"version":"4.9.0"},"reference-count":1200,"publisher":"ScopeMed","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":150,"URL":"https:\/\/www.openveterinaryjournal.com\/?sec=licenseinfo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.5455\/ovj.2026.v16.i5.42","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T05:07:07Z","timestamp":1780204027000},"source":"Crossref","is-referenced-by-count":1,"title":["&lt;b&gt;Decoding antidengue serotype-3 (DENV-3) mechanism of natural glycosides from &lt;i&gt;Alpinia purpurata&lt;\/i&gt;: Molecular docking and &lt;i&gt;in vitro&lt;\/i&gt; insights into viral entry, cytokine storm modulation, and endogenous antioxidant defense activation&lt;\/b&gt;"],"prefix":"10.5455","member":"3407","reference":[{"key":"ref1","unstructured":"1. DC-SIGN (CD209)Initial binding of DENV to dendritic cells"},{"key":"ref2","unstructured":"through glycoprotein E interactionQ9NNX6 (Begum et al. , 2019)"},{"key":"ref3","unstructured":"2. CD300aPhospholipid receptors that directly interact with"},{"key":"ref4","unstructured":"DENV particles and enhance infectionQ9UGN4 (Carnec et al. , 2015)"},{"key":"ref5","unstructured":"3.Interleukin-1 beta"},{"key":"ref6","unstructured":"(IL-1\u03b2)As a proinflammatory cytokine that serves as a"},{"key":"ref7","unstructured":"biomarker indicator of dengue severityP01584 (Sari et al. , 2025)"},{"key":"ref8","unstructured":"4. Superoxide dismutaseActs as an endogenous antioxidant that plays a"},{"key":"ref9","unstructured":"role in suppressing the production of reactive"},{"key":"ref10","unstructured":"oxygen species when dengue infection occurs.P00441(Lozano-parra et al. ,"},{"key":"ref11","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref13","unstructured":"2990was performed using the pkCSM webserver (https:\/\/"},{"key":"ref14","unstructured":"biosig.lab.uq.edu.au\/pkcsm\/). The pkCSM webserver"},{"key":"ref15","unstructured":"analyzes the relationship between the molecular"},{"key":"ref16","unstructured":"structure presented in the form of SMILES code of the"},{"key":"ref17","unstructured":"compound and the pharmacokinetic behavior of the"},{"key":"ref18","unstructured":"drug in the body, which can be used as an evaluation"},{"key":"ref19","unstructured":"of the safety of the compound when in the body."},{"key":"ref20","unstructured":"There are five major groups of parameters, namely"},{"key":"ref21","unstructured":"absorption, distribution, metabolism, excretion,"},{"key":"ref22","unstructured":"and toxicity, which are analyzed in this ADMET"},{"key":"ref23","unstructured":"screening, with each parameter group having its own"},{"key":"ref24","unstructured":"sub-parameters (Fatima et al., 2020; Klimoszek et al.,"},{"key":"ref25","unstructured":"2024; Banerjee et al., 2024). Furthermore, the specific"},{"key":"ref26","unstructured":"toxicity profile of glycoside compounds with the best"},{"key":"ref27","unstructured":"bioactivity potential was predicted using the ProTox"},{"key":"ref28","unstructured":"3.0 webserver (https:\/\/tox.charite.de\/protox3\/)."},{"key":"ref29","unstructured":"ProTox integrates molecular similarity, compound"},{"key":"ref30","unstructured":"pharmacophore models, fragments, and machine"},{"key":"ref31","unstructured":"learning models to predict the toxicity of a compound,"},{"key":"ref32","unstructured":"including acute toxicity (LD50), hepatotoxicity,"},{"key":"ref33","unstructured":"carcinogenicity, mutagenicity, immunotoxicity,"},{"key":"ref34","unstructured":"cytotoxicity, and organ-specific toxicities (Banerjee"},{"key":"ref35","unstructured":"et al., 2024)."},{"key":"ref36","unstructured":"Molecular dynamics simulation for validation of"},{"key":"ref37","unstructured":"docking results"},{"key":"ref38","unstructured":"The molecular docking experiment results were"},{"key":"ref39","unstructured":"validated using the CABS-flex 3.0 webserver (https:\/\/"},{"key":"ref40","unstructured":"lcbio.pl\/cabsflex3\/). The results with the best binding"},{"key":"ref41","unstructured":"affinity values were used for validation to observe the"},{"key":"ref42","unstructured":"properties of the drug when attached to the protein ring."},{"key":"ref43","unstructured":"The molecular docking results were validated using"},{"key":"ref44","unstructured":"several parameters, such as protein rigidity, restraint"},{"key":"ref45","unstructured":"settings, C-alpha restraints weight, side-chain restraint"},{"key":"ref46","unstructured":"weight, temperature range, trajectory, number of"},{"key":"ref47","unstructured":"cycles, and RNG seed in nanoseconds (ns) (Shivanika"},{"key":"ref48","unstructured":"S Deepak et al. , 2022)."},{"key":"ref49","unstructured":"Statistical analysis"},{"key":"ref50","unstructured":"The data were statistically analyzed using SPSS 21"},{"key":"ref51","unstructured":"software (SPSS Inc., Chicago, IL). Data were analyzed"},{"key":"ref52","unstructured":"using t-test, and differences between mean values were"},{"key":"ref53","unstructured":"considered significant at p < 0.05. Meanwhile, for p > 0.05, non-significant differences were considered"},{"key":"ref54","unstructured":"between extract and control, and accepting H0."},{"key":"ref55","unstructured":"Ethical approval"},{"key":"ref56","unstructured":"Not needed for this study."},{"key":"ref57","unstructured":"In vitro antiviral assay results of inhibition of virus"},{"key":"ref58","unstructured":"replication"},{"key":"ref59","unstructured":"The ethanol extract of A. purpurata inhibits DENV-3"},{"key":"ref60","unstructured":"replication in a concentration-dependent manner. As"},{"key":"ref61","unstructured":"shown in Table  2, at a concentration of 50 \u00b5g\/ml, the"},{"key":"ref62","unstructured":"extract provided 86.82% inhibition of the cytopathic"},{"key":"ref63","unstructured":"effect (CPE), which decreased to 71.74% at 100 \u00b5g\/"},{"key":"ref64","unstructured":"ml and 5.59% at 150 \u00b5g\/ml. The EC50 value of 105.81"},{"key":"ref65","unstructured":"\u00b5g\/ml indicates moderate effectiveness against DENV-"},{"key":"ref66","unstructured":"3, which is comparable to that of the quercetin control"},{"key":"ref67","unstructured":"(EC50 = 92.69 \u00b5g\/ml). The natural glycoside content in"},{"key":"ref68","unstructured":"A. purpurata extract can be a natural antiviral source"},{"key":"ref69","unstructured":"against DENV-3."},{"key":"ref70","unstructured":"The highest inhibitory effect at a concentration of 50"},{"key":"ref71","unstructured":"\u00b5g\/ml in this study indicates that at low doses, the"},{"key":"ref72","unstructured":"active compounds in the extract are still within the"},{"key":"ref73","unstructured":"non-toxic range for host cells, thereby effectively"},{"key":"ref74","unstructured":"inhibiting viral replication. The decrease in activity"},{"key":"ref75","unstructured":"at higher concentrations may be attributed to mild"},{"key":"ref76","unstructured":"cytotoxic effects or oxidative stress, which reduces"},{"key":"ref77","unstructured":"cell viability and viral inhibition effectiveness. The"},{"key":"ref78","unstructured":"recorded luminescence values also support this result,"},{"key":"ref79","unstructured":"as higher extract concentrations corresponded to lower"},{"key":"ref80","unstructured":"luminescence signals due to reduced viral infectivity."},{"key":"ref81","unstructured":"However, at a concentration of 150 \u00b5g\/mL, the"},{"key":"ref82","unstructured":"luminescence value dropped sharply, possibly due to"},{"key":"ref83","unstructured":"cellular metabolic disturbances caused by an excess of"},{"key":"ref84","unstructured":"active compounds in the extract."},{"key":"ref85","unstructured":"The inhibitory activity in Table 2 likely involves a"},{"key":"ref86","unstructured":"synergistic mechanism between virus attachment"},{"key":"ref87","unstructured":"inhibition and intracellular immune response"},{"key":"ref88","unstructured":"modification. This mechanism can also be observed in"},{"key":"ref89","unstructured":"the natural compounds \u03b1-mangostin and artesunic acid,"},{"key":"ref90","unstructured":"which suppress DENV replication through multiprotein"},{"key":"ref91","unstructured":"interaction in the early and late phases of the virus life"},{"key":"ref92","unstructured":"cycle.Table 2. Antiviral assay of the extract against DENV-3 infection."},{"key":"ref93","unstructured":"Concentration"},{"key":"ref94","unstructured":"(\u00b5g\/ml)Luminescence"},{"key":"ref95","unstructured":"1 2 3Treatment"},{"key":"ref96","unstructured":"Medium(control DENV"},{"key":"ref97","unstructured":"+ control cell) -"},{"key":"ref98","unstructured":"control medium"},{"key":"ref99","unstructured":"50 1.77 \u00d7 10\u2077 1.76 \u00d7 10\u2077 1.95 \u00d7 10\u2077 1.83 \u00d7 10\u2077 1.83 \u00d7 10\u2077 2.10 \u00d7 10\u2077 86.82"},{"key":"ref100","unstructured":"100 1.53 \u00d7 10\u2077 1.39 \u00d7 10\u2077 1.62 \u00d7 10\u2077 1.51 \u00d7 10\u2077 1.51 \u00d7 10\u2077 2.10 \u00d7 10\u2077 71.74"},{"key":"ref101","unstructured":"150 1.23 \u00d7 1069.04 \u00d7 1051.40 \u00d7 1061.18 \u00d7 1061.18 \u00d7 1062.10 \u00d7 10\u2077 5.59"},{"key":"ref102","unstructured":"Control of DENV"},{"key":"ref103","unstructured":"+ Control Cell2.11 \u00d7 10\u2077 2.10 \u00d7 10\u2077 2.10 \u00d7 10\u2077 2.10 \u00d7 10\u2077"},{"key":"ref104","unstructured":"Control Medium 1.15 \u00d7 1033.23 \u00d7 1022.76 \u00d7 1025.83 \u00d7 102"},{"key":"ref105","unstructured":"EC50 extract 105.8107 \u00b5g\/mL"},{"key":"ref106","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref108","unstructured":"2991The downward trend in CPE percentage in Figure 1"},{"key":"ref109","unstructured":"is consistent with the increasing concentration of A."},{"key":"ref110","unstructured":"purpurata extract against DENV-3 infection in Vero"},{"key":"ref111","unstructured":"E6 cells. This phenomenon is commonly found in plant"},{"key":"ref112","unstructured":"extracts rich in polyphenol and glycoside secondary"},{"key":"ref113","unstructured":"metabolites. At low doses, active compounds tend to"},{"key":"ref114","unstructured":"work optimally in suppressing viral replication through"},{"key":"ref115","unstructured":"a mechanism that inhibits virus attachment to cell"},{"key":"ref116","unstructured":"receptors without disrupting cell viability. However, at"},{"key":"ref117","unstructured":"higher doses, the accumulation of phenolic compounds"},{"key":"ref118","unstructured":"can increase oxidative stress and disrupt the integrity"},{"key":"ref119","unstructured":"of the host cell membrane. This can reduce overall"},{"key":"ref120","unstructured":"antiviral effectiveness (Rosmalena et al. , 2019)."},{"key":"ref121","unstructured":"At low to moderate doses, the active compounds"},{"key":"ref122","unstructured":"suppress viral replication by inhibiting viral attachment"},{"key":"ref123","unstructured":"to cell receptors without affecting host cell viability."},{"key":"ref124","unstructured":"However, excessive accumulation of phenolic"},{"key":"ref125","unstructured":"compounds at high doses may induce mild oxidative"},{"key":"ref126","unstructured":"stress and disrupt cell membrane integrity, which in"},{"key":"ref127","unstructured":"turn can reduce the antiviral effectiveness of the extract. Therefore, the decrease in the CPE curve at higher"},{"key":"ref128","unstructured":"concentrations may also reflect a shift in the antiviral"},{"key":"ref129","unstructured":"mechanism of action\u2014from early-stage (penetration)"},{"key":"ref130","unstructured":"inhibition to viral replication suppression within Vero"},{"key":"ref131","unstructured":"A comparison between the antiviral test results of A."},{"key":"ref132","unstructured":"purpurata extract (Table  2, Fig. 1) and quercetin control"},{"key":"ref133","unstructured":"(Table 3, Fig. 2) showed a similar biological response"},{"key":"ref134","unstructured":"pattern, but with different levels of effectiveness. At"},{"key":"ref135","unstructured":"a concentration of 50 \u00b5g\/mL, A. purpurata extract"},{"key":"ref136","unstructured":"reduced cytopathic effects by 86.82%, whereas"},{"key":"ref137","unstructured":"quercetin reduced cytopathic effects by 91.12% at"},{"key":"ref138","unstructured":"the same concentration. Although this difference is"},{"key":"ref139","unstructured":"relatively small, the EC50 value of the extract is slightly"},{"key":"ref140","unstructured":"lower than that of quercetin, indicating that the antiviral"},{"key":"ref141","unstructured":"bioactivity of the extract is similar to that of pure"},{"key":"ref142","unstructured":"flavonoid compounds. Thus, the glycoside compounds"},{"key":"ref143","unstructured":"in the A. purpurata extract have competitive antiviral"},{"key":"ref144","unstructured":"potential despite originating from a mixture of natural"},{"key":"ref145","unstructured":"secondary metabolites.Table 3. Antiviral assay of quercetin control against DENV-3 infection."},{"key":"ref146","unstructured":"Concentration"},{"key":"ref147","unstructured":"(\u00b5g\/ml)Luminescence"},{"key":"ref148","unstructured":"1 2 3Treatment"},{"key":"ref149","unstructured":"Medium(control DENV"},{"key":"ref150","unstructured":"+ control cell) -"},{"key":"ref151","unstructured":"control medium"},{"key":"ref152","unstructured":"50 1.82 \u00d7 10\u2077 1.76 \u00d7 10\u2077 1.74 \u00d7 10\u2077 1.77 \u00d7 10\u2077 1.77 \u00d7 10\u2077 1.95 \u00d7 10\u2077 91.12"},{"key":"ref153","unstructured":"100 7.33 \u00d7 1067.12 \u00d7 1068.02 \u00d7 1067.49 \u00d7 1067.49 \u00d7 1061.95 \u00d7 10\u2077 38.49"},{"key":"ref154","unstructured":"150 1.08 \u00d7 1058.92 \u00d7 1041.16 \u00d7 1051.04 \u00d7 1051.04 \u00d7 1051.95 \u00d7 10\u2077 0.53"},{"key":"ref155","unstructured":"Control of DENV"},{"key":"ref156","unstructured":"+ Control Cell1.94 \u00d7 10\u2077 1.97 \u00d7 10\u2077 1.93 \u00d7 10\u2077 1.95 \u00d7 10\u2077"},{"key":"ref157","unstructured":"Control Medium 1.15 \u00d7 1033.23 \u00d7 1022.76 \u00d7 1025.83 \u00d7 102"},{"key":"ref158","unstructured":"EC50 control 92.6923 \u00b5g\/mL"},{"key":"ref159","unstructured":"Fig. 1. Cytopathic effect percentage of extracts that inhibit DENV-3 infection in the cell line."},{"key":"ref160","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref161","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref162","unstructured":"2992The downward trend in CPE percentage in both"},{"key":"ref163","unstructured":"samples also showed a dose-dependent biphasic"},{"key":"ref164","unstructured":"response pattern, in which antiviral efficacy increased"},{"key":"ref165","unstructured":"at low to medium doses but decreased at high doses"},{"key":"ref166","unstructured":"(150 \u00b5g\/mL). Although the control had a better EC50"},{"key":"ref167","unstructured":"value than the test extract, the A. purpurata extract"},{"key":"ref168","unstructured":"showed the potential advantage of a multicomponent"},{"key":"ref169","unstructured":"synergistic effect. Natural glycoside components,"},{"key":"ref170","unstructured":"such as quercetin-3-O-rutinoside, kaempferol-3-O-"},{"key":"ref171","unstructured":"glucuronide, and sitosteryl-3-O-6-palmitoyl-\u03b2-D-"},{"key":"ref172","unstructured":"glucoside, can act through various targets, including"},{"key":"ref173","unstructured":"inhibition of virus binding to DC-SIGN\/CD209"},{"key":"ref174","unstructured":"receptors and modulation of inflammatory pathways"},{"key":"ref175","unstructured":"via IL-1\u03b2. This multitarget protein approach makes"},{"key":"ref176","unstructured":"the extract more relevant than single compounds for"},{"key":"ref177","unstructured":"natural drug development."},{"key":"ref178","unstructured":"Statistical test results showed no significant difference"},{"key":"ref179","unstructured":"between the extract test group and the control group"},{"key":"ref180","unstructured":"(p > 0.05). This value is greater than the significance"},{"key":"ref181","unstructured":"threshold of 0.05 (Table 4); therefore, the anti-dengue"},{"key":"ref182","unstructured":"activity of A. purpurata extract against DENV-3 is"},{"key":"ref183","unstructured":"comparable to quercetin. This finding is consistent"},{"key":"ref184","unstructured":"with several previous studies reporting that flavonoids"},{"key":"ref185","unstructured":"and polyphenols from plants have similar antiviral"},{"key":"ref186","unstructured":"mechanisms by inhibiting dengue virus replication"},{"key":"ref187","unstructured":"and attachment to host cells. Interestingly, quercetin"},{"key":"ref188","unstructured":"and fisetin can reduce DENV-2 and DENV-3 virus"},{"key":"ref189","unstructured":"titers and suppress proinflammatory cytokine secretion"},{"key":"ref190","unstructured":"during infection (Jasso-Miranda et al., 2019). Therefore, further predictions using molecular docking"},{"key":"ref191","unstructured":"and molecular dynamics experiments are needed to"},{"key":"ref192","unstructured":"identify potential single compounds from A. purpurata"},{"key":"ref193","unstructured":"extract, particularly from the abundant glycoside group"},{"key":"ref194","unstructured":"in the plant."},{"key":"ref195","unstructured":"Molecular docking of glycosides and test receptors"},{"key":"ref196","unstructured":"The in silico  analysis in Table  5 shows that the main"},{"key":"ref197","unstructured":"glycoside compounds from A. purpurata have a strong"},{"key":"ref198","unstructured":"binding affinity to host cell receptors that play a role in"},{"key":"ref199","unstructured":"DENV infection and immune regulation. The highest"},{"key":"ref200","unstructured":"binding energy, greater than that of the control, was"},{"key":"ref201","unstructured":"found in the compound quercetin-3-O-rutinoside (DC-"},{"key":"ref202","unstructured":"SIGN = \u22127.8 kcal\/mol; CD300a = \u22127.1 kcal\/mol;"},{"key":"ref203","unstructured":"IL-1\u03b2 = \u22127.2 kcal\/mol; SOD = \u22127.0 kcal\/mol). This"},{"key":"ref204","unstructured":"pattern indicates that A. purpurata glycosides have"},{"key":"ref205","unstructured":"the potential to inhibit virus binding and stabilize the"},{"key":"ref206","unstructured":"cellular immune response."},{"key":"ref207","unstructured":"In Table 5, strong interactions were detected through"},{"key":"ref208","unstructured":"the amino acid residues Gln282(A), Ser283(A),"},{"key":"ref209","unstructured":"Ile352(A), and Trp236(A), which contribute to the"},{"key":"ref210","unstructured":"formation of hydrogen bonds and Van der Waals forces."},{"key":"ref211","unstructured":"This interaction pattern indicates that the glycoside"},{"key":"ref212","unstructured":"can inhibit the attachment of viral particles to the DC-"},{"key":"ref213","unstructured":"SIGN receptor, which serves as the main entry point"},{"key":"ref214","unstructured":"for DENV-3 into host cells. The glycoside compound"},{"key":"ref215","unstructured":"quercetin-3-O-rutinoside inhibited DC-SIGN and"},{"key":"ref216","unstructured":"showed a significantly stronger binding pattern than"},{"key":"ref217","unstructured":"the positive control (\u22126.8 kcal\/mol), suggesting that the"},{"key":"ref218","unstructured":"Fig. 2. Cytopathic effect percentage of the control that inhibited DENV-3 infection in the cell line."},{"key":"ref219","unstructured":"Table 4. Analysis of antiviral assay results."},{"key":"ref220","unstructured":"Group EC50 (\u00b5g\/mL) n Normality Test Homogenity TestP-value of"},{"key":"ref221","unstructured":"the t-testHypotesis"},{"key":"ref222","unstructured":"Extract 105.8107 \u00b1 9.1 3Passed Passed 0.701 Accept H0Control 92.6923 \u00b1 8.8 3"},{"key":"ref223","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref224","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref225","unstructured":"2993Table 5. Molecular docking experiment and antiviral prediction results for each glycoside-receptor complexes."},{"key":"ref226","unstructured":"Compounds ReceptorBinding"},{"key":"ref227","unstructured":"(kcal\/mol)Root Mean"},{"key":"ref228","unstructured":"(RMSD) (\u00c5)Types of"},{"key":"ref229","unstructured":"interactionsAmino acid residuesAntiviral"},{"key":"ref230","unstructured":"predictionReferences"},{"key":"ref231","unstructured":"Sitosteryl-"},{"key":"ref232","unstructured":"palmitoyl-\u03b2-"},{"key":"ref233","unstructured":"D-glucosideDC-SIGN"},{"key":"ref234","unstructured":"(CD209)\u20137.3 16.873vdwGln282(A), Ser283(A), Ile352(A), Ser247(A), Asn248(A),"},{"key":"ref235","unstructured":"Phe245(A), Thr237(A), Gln189(A), Trp234(A), Gln188(A)"},{"key":"ref236","unstructured":"0.241 0.065(Villaflores et"},{"key":"ref237","unstructured":"al., 2010)HI Met246(A), Tyr192(A)"},{"key":"ref238","unstructured":"PHI Glu285(A), Trp236(A), Ser286(A), Arg288(A)"},{"key":"ref239","unstructured":"CD300a \u20137.1 1.157vdwLys60(A), Leu90(A), Tyr101(A), Leu93(A), Arg74(A),"},{"key":"ref240","unstructured":"Asp59(A), Glu96(A), Gly73(A)"},{"key":"ref241","unstructured":"HI Val75(A), Ile61(A)"},{"key":"ref242","unstructured":"PHI Asp97(A), Thr94(A), Asm72(A), Arg51(A)"},{"key":"ref243","unstructured":"IL-1\u03b2 \u20137.0 2.135vdwHis121(A), Glu134(A), Ser143(A), Thr138(A), His64(A),"},{"key":"ref244","unstructured":"His49(A), Ser69(A), Asn66(A)"},{"key":"ref245","unstructured":"HI His81(A), Pro63(A)"},{"key":"ref246","unstructured":"PHI Gly142(A)"},{"key":"ref247","unstructured":"Unfavorable"},{"key":"ref248","unstructured":"donor-donorArg144(A)"},{"key":"ref249","unstructured":"SOD \u20136.9 1.105vdwAsn66(A), Thr138(A), His64(A), His121(A), Ser143(A),"},{"key":"ref250","unstructured":"His49(A), Arg70(A), Thr136(A)"},{"key":"ref251","unstructured":"HI Lys137(A), Pro63(A), Lys71(A), His81(A)"},{"key":"ref252","unstructured":"PHI Glu134(A), Gly142(A)"},{"key":"ref253","unstructured":"Unfavorable"},{"key":"ref254","unstructured":"donor-donorArg144(A)"},{"key":"ref255","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref256","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref257","unstructured":"Compounds ReceptorBinding"},{"key":"ref258","unstructured":"(kcal\/mol)Root Mean"},{"key":"ref259","unstructured":"(RMSD) (\u00c5)Types of"},{"key":"ref260","unstructured":"interactionsAmino acid residuesAntiviral"},{"key":"ref261","unstructured":"predictionReferences"},{"key":"ref262","unstructured":"Quercetin-3-"},{"key":"ref263","unstructured":"O-rutinoside DC-SIGN"},{"key":"ref264","unstructured":"(CD209)\u20137.8 2.618 vdw Ser359(A), Pro231(A), Lys185(A), Pro183(A), Leu228(A),"},{"key":"ref265","unstructured":"Pro137(A), Pro91(A), Ser94(A) Ser361(A)"},{"key":"ref266","unstructured":"0.263 0.052(Vict\u00f3rio et"},{"key":"ref267","unstructured":"Suzery et al. ,"},{"key":"ref268","unstructured":"2019)PHI Lys93(A), Glu92(A), Glu364(A), Cys360(A), Ala358(A),"},{"key":"ref269","unstructured":"Pi-anion Glu138(A)"},{"key":"ref270","unstructured":"CD300a \u20137.1 16.578 vdw Tyr101(A), Glu99(A), Asp97(A), Glu95(A), Gln54(A),"},{"key":"ref271","unstructured":"HI Pro52(A)"},{"key":"ref272","unstructured":"PHI Glu96(A), Ala98(A), Thr100(A), Glu121(A)"},{"key":"ref273","unstructured":"Unfavorable"},{"key":"ref274","unstructured":"donor-donorArg51(A)"},{"key":"ref275","unstructured":"IL-1\u03b2 \u20137.2 26.742 vdw Ser161(A), Pro203(A), Lys204(A), Pro207(A), Ala117(A),"},{"key":"ref276","unstructured":"Lys210(A), Asn205(A), Glu180(A), Lys181(A)"},{"key":"ref277","unstructured":"HI Lys208(A), Lys179(A), Pro118(A)"},{"key":"ref278","unstructured":"PHI Leu178(A), Tyr184(A), Ser121(A), Val119(A)"},{"key":"ref279","unstructured":"Unfavorable"},{"key":"ref280","unstructured":"donor-donorLys209(A), Ser159(A)"},{"key":"ref281","unstructured":"SOD \u20137.0 21.975 vdw Leu68(A), Ser103(A), Gln23(A), Gly28(A), Ser26(A),"},{"key":"ref282","unstructured":"Gly109(A), Asp110(A), Lys76(A), Asp77(A), Arg80(A)"},{"key":"ref283","unstructured":"HI Val104(A)"},{"key":"ref284","unstructured":"PHI His111(A), Ser108(A), Arg70(A), Glu78(A)"},{"key":"ref285","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref286","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref287","unstructured":"2995Compounds ReceptorBinding"},{"key":"ref288","unstructured":"(kcal\/mol)Root Mean"},{"key":"ref289","unstructured":"(RMSD) (\u00c5)Types of"},{"key":"ref290","unstructured":"interactionsAmino acid residuesAntiviral"},{"key":"ref291","unstructured":"predictionReferences"},{"key":"ref292","unstructured":"Kaempferol-"},{"key":"ref293","unstructured":"glucuronideDC-SIGN"},{"key":"ref294","unstructured":"(CD209)\u20137.7 13.669 vdw Ala357(A), Cys243(A), Pro231(A), Cys232(A), Gly264(A),"},{"key":"ref295","unstructured":"Val263(A), Cys232(A), Glu226(A), Cys229(A), Asp363(A)0.258 0.055"},{"key":"ref296","unstructured":"HI Pro233(A)"},{"key":"ref297","unstructured":"PHI His230(A), Leu228(A), Trp234(A)"},{"key":"ref298","unstructured":"Pi-cation Lys355(A)"},{"key":"ref299","unstructured":"CD300a \u20137.1 22.801 vdw Gln35(A), Phe86(A), Thr87(A), Ile77(A), Gly69(A),"},{"key":"ref300","unstructured":"Lys70(A), Arg71(A), Glu91(A), Thr89(A)"},{"key":"ref301","unstructured":"PHI Ser33(A), Ser76(A), Ser80(A), Asn83(A), Ser85(A)"},{"key":"ref302","unstructured":"IL1-\u03b2 \u20137.2 24.728 vdw Val119(A), Ser121(A), Arg120(A), Ala117(A), Ser269(A),"},{"key":"ref303","unstructured":"Leu122(A), Asn123(A), Gly177(A), Leu183(A),"},{"key":"ref304","unstructured":"Leu178(A), Lys179(A), Lys181(A), Asn182(A), Tyr206(A),"},{"key":"ref305","unstructured":"HI Pro207(A)"},{"key":"ref306","unstructured":"PHI Ser159(A), Tyr184(A)"},{"key":"ref307","unstructured":"SOD \u20136.9 21.541 vdw Leu68(A), Ser103(A), Arg80(A), Asp77(A), Lys76(A),"},{"key":"ref308","unstructured":"Asp110(A), Gly109(A), Ser26(A), Gln23(A), Gly28(A)"},{"key":"ref309","unstructured":"HI Val104(A)"},{"key":"ref310","unstructured":"PHI Glu78(A), Arg70(A), His111(A), Ser108(A), Ser106(A),"},{"key":"ref311","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref312","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref313","unstructured":"Compounds ReceptorBinding"},{"key":"ref314","unstructured":"(kcal\/mol)Root Mean"},{"key":"ref315","unstructured":"(RMSD) (\u00c5)Types of"},{"key":"ref316","unstructured":"interactionsAmino acid residuesAntiviral"},{"key":"ref317","unstructured":"predictionReferences"},{"key":"ref318","unstructured":"Vanillic acid"},{"key":"ref319","unstructured":"(V AG)DC-SIGN"},{"key":"ref320","unstructured":"(CD209)\u20136.2 2.793 vdw Lys185(A), Thr237(A), Arg288(A), Gln282(A), Glu235(A),"},{"key":"ref321","unstructured":"Tyr192(A), Trp234(A), Gln188(A)0.267 0.050"},{"key":"ref322","unstructured":"(Begum et al. ,"},{"key":"ref323","unstructured":"2019)PHI Gln189(A), Asn248(A), Trp236(A)"},{"key":"ref324","unstructured":"Pi-sigma Met246(A)"},{"key":"ref325","unstructured":"Unfavorable"},{"key":"ref326","unstructured":"donor-donorPhe238(A)"},{"key":"ref327","unstructured":"CD300a \u20135.6 1.534 vdw Trp109(A), Leu57(A), Cys58(A), Tyr48(A), Val117(A),"},{"key":"ref328","unstructured":"HI Pro53(A)"},{"key":"ref329","unstructured":"PHI Phe113(A), His114(A), Asp115(A)"},{"key":"ref330","unstructured":"IL-1\u03b2 \u20136.2 2.573 vdw Glu180(A), Pro207(A), Tyr184(A), Asn182(A), Lys181(A),"},{"key":"ref331","unstructured":"Gly177(A), Asn123(A), Ser121(A)"},{"key":"ref332","unstructured":"HI Lys179(A)"},{"key":"ref333","unstructured":"PHI Tyr206(A), Pro203(A), Ser159(A)"},{"key":"ref334","unstructured":"Unfavorable"},{"key":"ref335","unstructured":"acceptorSer269(A)"},{"key":"ref336","unstructured":"SOD \u20135.8 5.547 vdw Lys71(A), Thr138(A)"},{"key":"ref337","unstructured":"HI Pro63(A), Lys137(A)"},{"key":"ref338","unstructured":"PHI Ser69(A), Thr136(A), His64(A), Asn66(A), Arg70(A)"},{"key":"ref339","unstructured":"Pi-cation His81(A)"},{"key":"ref340","unstructured":"Unfavorable"},{"key":"ref341","unstructured":"donor-donorHis72(A)"},{"key":"ref342","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref343","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref344","unstructured":"2997Compounds ReceptorBinding"},{"key":"ref345","unstructured":"(kcal\/mol)Root Mean"},{"key":"ref346","unstructured":"(RMSD) (\u00c5)Types of"},{"key":"ref347","unstructured":"interactionsAmino acid residuesAntiviral"},{"key":"ref348","unstructured":"predictionReferences"},{"key":"ref349","unstructured":"(Control)DC-SIGN"},{"key":"ref350","unstructured":"(CD209)\u20136.8 2.251 vdw Phe238(A), Thr237(A), Trp236(A), Tyr192(A), Gln282(A) 0.262 0.053 -"},{"key":"ref351","unstructured":"PHI Ser286(A), Gln189(A), Glu235(A), Asn248(A), Arg288(A),"},{"key":"ref352","unstructured":"Ser247(A), Met246(A)"},{"key":"ref353","unstructured":"CD300a \u20136.4 1.463 vdw Lys60(A), Trp109(A), Phe56(A), Pro53(A), Trp102(A),"},{"key":"ref354","unstructured":"Val117(A), Cys58(A), Thr107(A)"},{"key":"ref355","unstructured":"HI Leu57(A)"},{"key":"ref356","unstructured":"PHI Asp106(A), Asp115(A), Tyr48(A)"},{"key":"ref357","unstructured":"Pi-pi T-shaped His114(A)"},{"key":"ref358","unstructured":"IL-1\u03b2 \u20136.7 2.08 vdw Ser269(A), Lys179(A), Glu180(A), Leu178(A), Gly177(A),"},{"key":"ref359","unstructured":"Leu183(A), Tyr184(A), Asn182(A), Ser159(A), Ser121(A)"},{"key":"ref360","unstructured":"HI Pro207(A)"},{"key":"ref361","unstructured":"PHI Lys181(A), Asn123(A)"},{"key":"ref362","unstructured":"SOD \u20136.5 14.576 vdw Val30(A), Ile105(A), Gln23(A), Ser106(A), Ser26(A),"},{"key":"ref363","unstructured":"Pro29(A), Val104(A), Asn27(A), Gly109(A)"},{"key":"ref364","unstructured":"PHI His111(A), Asp110(A), Ser103(A), Gly28(A)"},{"key":"ref365","unstructured":"acid glucosideDC-SIGN"},{"key":"ref366","unstructured":"(CD209)\u20136.4 15.763 vdw Leu368(A), Arg227(A), Cys229(A), Trp234(A), Cys232(A),"},{"key":"ref367","unstructured":"Pro233(A), Ala358(A), Asp363(A)0.312 0.033"},{"key":"ref368","unstructured":"PHI Leu228(A), His230(A), Glu226(A), Glu364(A)"},{"key":"ref369","unstructured":"Pi-pi stacked Phe367(A)"},{"key":"ref370","unstructured":"Pi-cation Lys141(A)"},{"key":"ref371","unstructured":"CD300a \u20135.5 2.512 vdw Ser19(A), Asp115(A), Tyr48(A), Cys58(A), Phe56(A),"},{"key":"ref372","unstructured":"Leu57(A), Trp109(A)"},{"key":"ref373","unstructured":"HI Val117(A)"},{"key":"ref374","unstructured":"PHI His114(a)"},{"key":"ref375","unstructured":"Pi-pi T-shaped Trp102(A)"},{"key":"ref376","unstructured":"IL-1\u03b2 \u20136.3 2.555 vdw Leu183(A), Asn182(A), Lys179(A), Leu178(A), Ser121(A),"},{"key":"ref377","unstructured":"Arg120(A), Val119(A), Ala117(A), Pro207(A), Tyr206(A)"},{"key":"ref378","unstructured":"PHI Glu180(A), Pro203(A), Lys181(A), Tyr184(A), Ser159(A)"},{"key":"ref379","unstructured":"SOD \u20135.7 3.573 vdw Lys71(A), His72(A), Asn66(A), His81(A), Pro63(A),"},{"key":"ref380","unstructured":"Thr138(A), Glu134(A)"},{"key":"ref381","unstructured":"HI Lys137(A)"},{"key":"ref382","unstructured":"PHI Ser69(A), Thr136(A), Arg70(A)"},{"key":"ref383","unstructured":"Vdw, van der Walls interaction; HI, hydrophobic interaction; PHI, hydrogen interaction; green shading, complexes with the highest binding affinity and antiviral potential."},{"key":"ref384","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref385","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref386","unstructured":"2998compound from the extract possesses a better inhibitory"},{"key":"ref387","unstructured":"capacity in preventing viral entry into the host."},{"key":"ref388","unstructured":"In addition, glycoside compounds were found to interact"},{"key":"ref389","unstructured":"with the residues Lys60(A), Leu90(A), Arg74(A), and"},{"key":"ref390","unstructured":"Asp97(A) through hydrogen bonds and Van der Waals"},{"key":"ref391","unstructured":"forces on the CD300a receptor. This pattern illustrates"},{"key":"ref392","unstructured":"the potential of glycosides to modulate immune"},{"key":"ref393","unstructured":"activity, as CD300a functions as an immune signal"},{"key":"ref394","unstructured":"regulatory receptor that can be exploited by DENV-3"},{"key":"ref395","unstructured":"to suppress phagocytosis. The binding of glycosides"},{"key":"ref396","unstructured":"to these amino acid residues is presumed to inhibit the"},{"key":"ref397","unstructured":"CD300a-mediated inhibitory signals, thereby assisting"},{"key":"ref398","unstructured":"in the restoration of the immune response following"},{"key":"ref399","unstructured":"DENV-3 infection."},{"key":"ref400","unstructured":"Significant interactions were also detected between the"},{"key":"ref401","unstructured":"ligand and the IL-1\u03b2 receptor, in which the residues"},{"key":"ref402","unstructured":"His121(A), Glu134(A), and Gly142(A) were directly"},{"key":"ref403","unstructured":"involved in forming strong hydrogen bonds and Van"},{"key":"ref404","unstructured":"der Waals forces. These interactions contribute to the"},{"key":"ref405","unstructured":"suppression of signaling pathway activation that leads"},{"key":"ref406","unstructured":"to the production of the proinflammatory cytokine IL-"},{"key":"ref407","unstructured":"1\u03b2 during cytokine storm conditions within the cell."},{"key":"ref408","unstructured":"This pattern indicates that the glycoside compounds of"},{"key":"ref409","unstructured":"A. purpurata function not only as anti-dengue agents"},{"key":"ref410","unstructured":"but also as natural immunomodulators that reduce"},{"key":"ref411","unstructured":"the secretion of proinflammatory cytokines during"},{"key":"ref412","unstructured":"Meanwhile, hydrogen bonds were naturally formed"},{"key":"ref413","unstructured":"between the ligand and the residues His111(A),"},{"key":"ref414","unstructured":"Asp110(A), and Ser103(A) on the SOD enzyme, which"},{"key":"ref415","unstructured":"play a role in maintaining the stability of the enzyme\u2019s"},{"key":"ref416","unstructured":"active site. The attachment of the tested compound to"},{"key":"ref417","unstructured":"these amino acid residues may help the cell activate"},{"key":"ref418","unstructured":"SOD enzyme secretion, thereby reducing free oxidants"},{"key":"ref419","unstructured":"in the body when cells experience stress due to dengue"},{"key":"ref420","unstructured":"infection. In addition, this interaction demonstrates the"},{"key":"ref421","unstructured":"potential of glycosides to enhance cellular antioxidant"},{"key":"ref422","unstructured":"defenses by preserving SOD enzyme function from"},{"key":"ref423","unstructured":"oxidative stress-induced damage. The stability of this"},{"key":"ref424","unstructured":"complex indicates that the active compounds of A."},{"key":"ref425","unstructured":"purpurata may support the cell\u2019s natural protective"},{"key":"ref426","unstructured":"mechanisms against increased free radicals during"},{"key":"ref427","unstructured":"Overall, Figure 3 supports the interactions shown in"},{"key":"ref428","unstructured":"Table  5, which describes the synergistic antiviral-"},{"key":"ref429","unstructured":"immunomodulator-antioxidant mechanism of A."},{"key":"ref430","unstructured":"purpurata extract. Glycoside compounds not only"},{"key":"ref431","unstructured":"inhibited virus binding to DC-SIGN receptors but also"},{"key":"ref432","unstructured":"suppressed the activation of proinflammatory cytokine"},{"key":"ref433","unstructured":"IL-1\u03b2, balance immune signaling through the regulation"},{"key":"ref434","unstructured":"of the CD300a protein, and strengthened the oxidative"},{"key":"ref435","unstructured":"defense system through the superoxide dismutase"},{"key":"ref436","unstructured":"enzyme. This combination of activities indicates that"},{"key":"ref437","unstructured":"A. purpurata works through multireceptor modulation,"},{"key":"ref438","unstructured":"which not only suppresses viral replication but also"},{"key":"ref439","unstructured":"reduces pathogenesis in severe dengue infection due to"},{"key":"ref440","unstructured":"immune hyperactivation.ADMET properties and specific toxicity of quercetin-3-"},{"key":"ref441","unstructured":"O-rutinoside"},{"key":"ref442","unstructured":"The aim of the ADMET analysis was to assess the"},{"key":"ref443","unstructured":"pharmacokinetic potential and safety of the main active"},{"key":"ref444","unstructured":"compound resulting from docking with the highest"},{"key":"ref445","unstructured":"binding affinity value, quercetin-3-O-rutinoside from"},{"key":"ref446","unstructured":"A. purpurata (Mvondo et al., 2021). This parameter is"},{"key":"ref447","unstructured":"important for assessing the suitability of the compound"},{"key":"ref448","unstructured":"as a drug candidate before conducting in vivo  or clinical"},{"key":"ref449","unstructured":"trials. The results in Table  6 show that the quercetin-3-"},{"key":"ref450","unstructured":"O-rutinoside compound has moderate solubility (log"},{"key":"ref451","unstructured":"S = \u22123.327), indicating a moderate ability to dissolve"},{"key":"ref452","unstructured":"in cells. However, the Caco2 permeability value"},{"key":"ref453","unstructured":"(\u22120.791 log Papp) and intestinal absorption of 28.49%"},{"key":"ref454","unstructured":"indicate that the absorption through human milk is"},{"key":"ref455","unstructured":"relatively lower due to the large glycoside structure"},{"key":"ref456","unstructured":"and high polarity. This compound is also detected as"},{"key":"ref457","unstructured":"a p-glycoprotein substrate and p-glycoprotein I and II"},{"key":"ref458","unstructured":"inhibitor, which means that an efflux mechanism that"},{"key":"ref459","unstructured":"limits oral bioavailability may occur (Fatima et al.,"},{"key":"ref460","unstructured":"2020; Klimoszek et al. , 2024)."},{"key":"ref461","unstructured":"The volume of distribution (VDss) value of \u22121.597 log"},{"key":"ref462","unstructured":"L\/kg indicates low distribution to peripheral tissues,"},{"key":"ref463","unstructured":"while the unbound fraction of 0.419 indicates that"},{"key":"ref464","unstructured":"nearly half of the compound is in free form in plasma,"},{"key":"ref465","unstructured":"allowing for effective pharmacological interactions."},{"key":"ref466","unstructured":"The BBB and CNS permeability values also indicate"},{"key":"ref467","unstructured":"that this compound is suitable  for preventing"},{"key":"ref468","unstructured":"neurotoxicity or CNS disorders."},{"key":"ref469","unstructured":"The compound quercetin-3-O-rutinoside is not a"},{"key":"ref470","unstructured":"CYP2D6 substrate but a CYP3A4 substrate in terms of"},{"key":"ref471","unstructured":"distribution parameters. This indicates the potential for"},{"key":"ref472","unstructured":"major metabolism via the cytochrome P450 pathway"},{"key":"ref473","unstructured":"in the liver. The absence of inhibitory activity against"},{"key":"ref474","unstructured":"major cytochrome P450 enzymes indicates a low risk of"},{"key":"ref475","unstructured":"drug interactions. This pattern is similar to the ADMET"},{"key":"ref476","unstructured":"profile of other natural flavonoid compounds, such as"},{"key":"ref477","unstructured":"kaempferol-3-glucuronide, which is metabolized via"},{"key":"ref478","unstructured":"CYP3A4 without causing hepatotoxicity (Shivanika S"},{"key":"ref479","unstructured":"Deepak et al. , 2022)."},{"key":"ref480","unstructured":"In terms of excretion parameters, the total clearance"},{"key":"ref481","unstructured":"value of 0.187 log ml\/min\/kg indicates slower excretion"},{"key":"ref482","unstructured":"and supports a moderate half-life. Quercetin-3-O-"},{"key":"ref483","unstructured":"rutinoside is not a renal OCT2 substrate, indicating"},{"key":"ref484","unstructured":"that the main elimination route is hepatic or biliary"},{"key":"ref485","unstructured":"(Herdiansyah et al., 2024). In addition, based on"},{"key":"ref486","unstructured":"pkCSM predictions, quercetin-3-O-rutinoside does not"},{"key":"ref487","unstructured":"exhibit genetic toxicity (Ames test negative), is not"},{"key":"ref488","unstructured":"hepatotoxic, and does not cause skin sensitization."},{"key":"ref489","unstructured":"As shown in Figure 4, no hepatotoxic potential was"},{"key":"ref490","unstructured":"found. This indicates that the quercetin-3-O-rutinoside"},{"key":"ref491","unstructured":"compound cannot induce hepatocyte damage. This"},{"key":"ref492","unstructured":"result is consistent with the pkCSM prediction"},{"key":"ref493","unstructured":"for hepatotoxicity parameters. No mutagenic or"},{"key":"ref494","unstructured":"carcinogenic potential was found, indicating that"},{"key":"ref495","unstructured":"the compound does not contain genotoxic chemical"},{"key":"ref496","unstructured":"fragments, such as long conjugated aromatic rings"},{"key":"ref497","unstructured":"or active electrophilic substituents. Flavonoids with"},{"key":"ref498","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref499","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref500","unstructured":"Fig. 3. Interaction complex visualization of quercetin-3-O-rutinoside as the complex with the highest binding af finity."},{"key":"ref501","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref502","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref503","unstructured":"3000glycoside groups stabilize DNA through noncovalent"},{"key":"ref504","unstructured":"interactions that protect against gene mutations. The"},{"key":"ref505","unstructured":"absence of immunotoxicity indicates that quercetin-"},{"key":"ref506","unstructured":"3-O-rutinoside has immunomodulatory activity and"},{"key":"ref507","unstructured":"the potential to suppress proinflammatory cytokine"},{"key":"ref508","unstructured":"production and normalize CD300a receptor expression."},{"key":"ref509","unstructured":"The LD50 value of 5000 mg\/kg in the compound\u2019s"},{"key":"ref510","unstructured":"toxicity class 5 indicates a low tendency for acute"},{"key":"ref511","unstructured":"Molecular dynamics results as validation of the"},{"key":"ref512","unstructured":"molecular docking method"},{"key":"ref513","unstructured":"The results of molecular docking validation through"},{"key":"ref514","unstructured":"molecular dynamics show that the binding between"},{"key":"ref515","unstructured":"quercetin-3-O-rutinoside and CD300a, IL-1\u03b2, and SOD is stable. However, the complex between quercetin-3-"},{"key":"ref516","unstructured":"O-rutinoside and DC (CD209) has an RMSF value >"},{"key":"ref517","unstructured":"3 \u00c5. The instability of the bond between the receptor"},{"key":"ref518","unstructured":"and the ligand will affect protein rigidity and can lead"},{"key":"ref519","unstructured":"to physiological responses that are not as desired when"},{"key":"ref520","unstructured":"the compound is induced. Complexes with an RMSF"},{"key":"ref521","unstructured":"value < 2 \u00c5 are likely to be relatively more stable  in the"},{"key":"ref522","unstructured":"body and can trigger the physiological response of the"},{"key":"ref523","unstructured":"body (Utari et al. , 2025; Shobahah et al. , 2025)."},{"key":"ref524","unstructured":"To the best of our knowledge, this study is the first to"},{"key":"ref525","unstructured":"explore the potential of natural compounds from the"},{"key":"ref526","unstructured":"Alpinia genus against the dengue virus, particularly Table 6. ADMET properties of quercetin-3-O-rutinoside."},{"key":"ref527","unstructured":"Tipe Parameter Parameter Quercetin-3-O-"},{"key":"ref528","unstructured":"rutinosideUnit"},{"key":"ref529","unstructured":"Absorption Water solubility \u20133.327 Numeric (log mol\/L)"},{"key":"ref530","unstructured":"Absorption Caco2 permeability \u20130.791 Numeric (log Papp in 10\u20136 cm\/s)"},{"key":"ref531","unstructured":"Absorption Intestinal absorption in humans 28.495 Numeric (% Absorbed)"},{"key":"ref532","unstructured":"Absorption Skin Permeability \u20132.737 Numeric (log Kp)"},{"key":"ref533","unstructured":"Absorption P-glycoprotein substrate Yes Categorical (Yes\/No)"},{"key":"ref534","unstructured":"Absorption P-glycoprotein I inhibitor Yes Categorical (Yes\/No)"},{"key":"ref535","unstructured":"Absorption P-glycoprotein II inhibitor Yes Categorical (Yes\/No)"},{"key":"ref536","unstructured":"Distribution VDss (human) \u20131.597 Numeric (log L\/kg)"},{"key":"ref537","unstructured":"Distribution Unbound fraction (human) 0.419 Numeric (Fu)"},{"key":"ref538","unstructured":"Distribution BBB permeability \u20132.215 Numeric (log BB)"},{"key":"ref539","unstructured":"Distribution CNS permeability \u20134.842 Numeric (log PS)"},{"key":"ref540","unstructured":"Metabolism CYP2D6 substrate No Categorical (Yes\/No)"},{"key":"ref541","unstructured":"Metabolism CYP3A4 substrate Yes Categorical (Yes\/No)"},{"key":"ref542","unstructured":"Metabolism CYP1A2 inhibitors No Categorical (Yes\/No)"},{"key":"ref543","unstructured":"Metabolism CYP2C19 inhibitors No Categorical (Yes\/No)"},{"key":"ref544","unstructured":"Metabolism CYP2C9 inhibitors No Categorical (Yes\/No)"},{"key":"ref545","unstructured":"Metabolism CYP2D6 inhibitors No Categorical (Yes\/No)"},{"key":"ref546","unstructured":"Metabolism CYP3A4 inhibitors No Categorical (Yes\/No)"},{"key":"ref547","unstructured":"Excretion Total Clearance 0.187 Numeric (log mL\/min\/kg)"},{"key":"ref548","unstructured":"Excretion Renal OCT2 substrate No Categorical (Yes\/No)"},{"key":"ref549","unstructured":"Toxicity AMES toxicity No Categorical (Yes\/No)"},{"key":"ref550","unstructured":"Toxicity Maximum tolerated dose (human) 0.375 Numeric (log mg\/kg\/day)"},{"key":"ref551","unstructured":"Toxicity hERG I inhibitor No Categorical (Yes\/No)"},{"key":"ref552","unstructured":"Toxicity hERG II inhibitor Yes Categorical (Yes\/No)"},{"key":"ref553","unstructured":"Toxicity Oral rat acute toxicity (LD50) 1.526 Numeric (mol\/kg)"},{"key":"ref554","unstructured":"Toxicity Oral rat chronic toxicity (LOAEL) 2.231 Numeric (log mg\/kg bw\/day)"},{"key":"ref555","unstructured":"Toxicity Hepatotoxicity No Categorical (Yes\/No)"},{"key":"ref556","unstructured":"Toxicity Skin Sensitization No Categorical (Yes\/No)"},{"key":"ref557","unstructured":"Toxicity T.Pyriformis toxicity 0.285 Numeric (log \u00b5g\/L)"},{"key":"ref558","unstructured":"Toxicity Minnow toxicity 4.442 Numeric (log mM)"},{"key":"ref559","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref560","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref561","unstructured":"3001DENV-3. Previous studies have reported that several"},{"key":"ref562","unstructured":"species within the Alpinia  genus possess antiviral"},{"key":"ref563","unstructured":"potential, such as A. officinarum as a natural protease"},{"key":"ref564","unstructured":"inhibitor against the Zika virus (Gbore et al., 2023), A."},{"key":"ref565","unstructured":"zerumbet for reducing infection by ToMV and TMV"},{"key":"ref566","unstructured":"(Narusaka et al., 2020), and A. galanga for preventing"},{"key":"ref567","unstructured":"infection by BVDV (Herrmann et al., 2011). To date,"},{"key":"ref568","unstructured":"investigations into the antiviral potential of plants from"},{"key":"ref569","unstructured":"the Alpinia genus are still ongoing, as previous findings"},{"key":"ref570","unstructured":"have highlighted their promise as sources of natural"},{"key":"ref571","unstructured":"antiviral agents."},{"key":"ref572","unstructured":"In this study, the A. purpurata extract was found to"},{"key":"ref573","unstructured":"have potential as an anti-dengue agent by inhibiting"},{"key":"ref574","unstructured":"viral replication in vitro (Table  2). The EC50 values"},{"key":"ref575","unstructured":"obtained from both the extract and the control reflected"},{"key":"ref576","unstructured":"the decrease in viral replication activity. This reduction"},{"key":"ref577","unstructured":"in viral replication activity is presumed to be due to the"},{"key":"ref578","unstructured":"presence of bioactive compounds, such as flavonoids,"},{"key":"ref579","unstructured":"terpenoids, and natural glycosides, which can inhibit"},{"key":"ref580","unstructured":"the active site of the dengue virus protease enzyme."},{"key":"ref581","unstructured":"The mechanism of action of the A. purpurata extract"},{"key":"ref582","unstructured":"is believed to involve binding to the active site of"},{"key":"ref583","unstructured":"the viral enzyme that encodes replication and repair"},{"key":"ref584","unstructured":"processes when the virus is damaged by host immune cells (Zhang et al., 2016). The activity concentration"},{"key":"ref585","unstructured":"pattern against this inhibition agrees with the latest"},{"key":"ref586","unstructured":"research results on other medicinal plant extracts that"},{"key":"ref587","unstructured":"show similar activity against DENV-2 and DENV-3."},{"key":"ref588","unstructured":"Extracts of Vitex negundo, P . alba, and B. monnieri"},{"key":"ref589","unstructured":"have been reported to reduce virus titers and prevent"},{"key":"ref590","unstructured":"the formation of infection foci in Vero cell cultures"},{"key":"ref591","unstructured":"through a mechanism that inhibits the entry of viruses"},{"key":"ref592","unstructured":"into cells (Alagarasu et al., 2022). Ansori et al. (2021)"},{"key":"ref593","unstructured":"showed that natural polyphenolic compounds from"},{"key":"ref594","unstructured":"Pinus merkusii also exhibit antiviral activity with an"},{"key":"ref595","unstructured":"IC50 below 150 \u00b5g\/ml against DENV , confirming the"},{"key":"ref596","unstructured":"potential of tropical plant secondary metabolites as"},{"key":"ref597","unstructured":"DENV infection inhibitors (Ansori et al. , 2021)."},{"key":"ref598","unstructured":"The decrease in antiviral activity at high concentrations"},{"key":"ref599","unstructured":"can also be linked to mild cytotoxic effects, whereby the"},{"key":"ref600","unstructured":"extract affects cellular metabolism in the host. This can"},{"key":"ref601","unstructured":"be observed from the tests on Andrographis paniculata"},{"key":"ref602","unstructured":"and Curcuma longa, which also show similar patterns."},{"key":"ref603","unstructured":"Increasing the dose above the optimum limit can reduce"},{"key":"ref604","unstructured":"the selectivity index and antiviral activity (Ichsyani"},{"key":"ref605","unstructured":"et al., 2017; Ramalingam et al., 2018). A decrease in"},{"key":"ref606","unstructured":"the CPE curve in plant extracts may reflect a change"},{"key":"ref607","unstructured":"in the antiviral mechanism of action from the initial"},{"key":"ref608","unstructured":"Fig. 4. Results of the toxicity analysis of quercetin-3-O-rutinoside on specific organs."},{"key":"ref609","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref610","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref611","unstructured":"3002inhibition stage to the virus replication suppression"},{"key":"ref612","unstructured":"stage. Altamish et al. (2022)showed that extracts"},{"key":"ref613","unstructured":"containing quercetin and artesunic acid are effective"},{"key":"ref614","unstructured":"only within a certain concentration range because their"},{"key":"ref615","unstructured":"mechanism depends on temporary binding to viral"},{"key":"ref616","unstructured":"surface proteins or the NS3\/NS5 enzyme (Altamish et"},{"key":"ref617","unstructured":"al., 2022)."},{"key":"ref618","unstructured":"The analysis of natural glycosides from A. purpurata"},{"key":"ref619","unstructured":"against selected receptors using in silico  molecular"},{"key":"ref620","unstructured":"docking experiments (Table  5) and molecular"},{"key":"ref621","unstructured":"dynamics simulations (Fig. 5) also supports the in"},{"key":"ref622","unstructured":"vitro findings obtained earlier. Glycosides were used"},{"key":"ref623","unstructured":"in this study because previous research has revealed"},{"key":"ref624","unstructured":"their remarkable potential in triggering important"},{"key":"ref625","unstructured":"bioactivities within cells. Oleandrin, a natural"},{"key":"ref626","unstructured":"glycoside derived from Nerium oleander, was found to"},{"key":"ref627","unstructured":"perfectly bind to essential amino acid residues of viral"},{"key":"ref628","unstructured":"envelope receptors such as HIV , hepatitis B virus type"},{"key":"ref629","unstructured":"1 (HTLV-1), and severe acute respiratory syndrome"},{"key":"ref630","unstructured":"coronavirus 2 (SARS-CoV-2) (Newman et al., 2020)."},{"key":"ref631","unstructured":"Furthermore, Velandia et al. (2025) demonstrated that"},{"key":"ref632","unstructured":"the flavonoid class conjugated with sugar moieties in"},{"key":"ref633","unstructured":"the form of glycosides from 14 herbal plant extracts"},{"key":"ref634","unstructured":"exhibited stronger inhibitory activity against dengue"},{"key":"ref635","unstructured":"viral proteins than non-glycosylated flavonoid"},{"key":"ref636","unstructured":"aglycones (Velandia et al., 2025). In addition to their"},{"key":"ref637","unstructured":"direct antiviral activity, several studies have shown"},{"key":"ref638","unstructured":"that glycoside compounds can stabilize cell surfaces and reduce the expression of virus-binding receptors,"},{"key":"ref639","unstructured":"such as DC-SIGN and CD300a, which play important"},{"key":"ref640","unstructured":"roles in DENV internalization (Warfield et al., 2016)."},{"key":"ref641","unstructured":"These studies further strengthen the potential of natural"},{"key":"ref642","unstructured":"glycosides as safe and abundant antiviral agents in"},{"key":"ref643","unstructured":"medicinal plants."},{"key":"ref644","unstructured":"DC-SIGN (CD209) is the main receptor on DCs"},{"key":"ref645","unstructured":"that mediates DENV attachment through the C-type"},{"key":"ref646","unstructured":"carbohydrate domain. The docking results show that"},{"key":"ref647","unstructured":"the quercetin-3-O-rutinoside compound forms strong"},{"key":"ref648","unstructured":"hydrogen bonds with residues Lys93(A), Glu92(A),"},{"key":"ref649","unstructured":"Glu364(A), Cys360(A), Ala358(A), and Cys229(A)."},{"key":"ref650","unstructured":"The formation of these strong hydrogen bonds can"},{"key":"ref651","unstructured":"inhibit the binding of the mannosylated ligand from"},{"key":"ref652","unstructured":"the DENV envelope to this host receptor. Hsieh et al."},{"key":"ref653","unstructured":"(2020)revealed that increased expression of DC-SIGN"},{"key":"ref654","unstructured":"enhances DENV infection, suggesting that glycoside"},{"key":"ref655","unstructured":"binding at this site may inhibit the initial step of viral"},{"key":"ref656","unstructured":"invasion (Hsieh et al., 2020). Furthermore, a recent"},{"key":"ref657","unstructured":"study by Xue et al. (2021)supports that the blockade of"},{"key":"ref658","unstructured":"CD209 by glycoside ligands can reduce the affinity of"},{"key":"ref659","unstructured":"the pathogen for this receptor, making this mechanism"},{"key":"ref660","unstructured":"relevant for the inhibition of DENV-3 (Xue et al.,"},{"key":"ref661","unstructured":"CD300a is an immunomodulatory receptor that"},{"key":"ref662","unstructured":"regulates phagocytosis and inflammation inhibitory"},{"key":"ref663","unstructured":"signals. Docking shows that quercetin-3-O-rutinoside"},{"key":"ref664","unstructured":"binds strongly to residues Glu96(A), Ala98(A),"},{"key":"ref665","unstructured":"Fig. 5. Molecular dynamics of quercetin-3-O-rutinoside complexes."},{"key":"ref666","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref667","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref668","unstructured":"3003Thr100(A), and Glu121(A) in the CD300a extracellular"},{"key":"ref669","unstructured":"domain, with a binding energy of -7.1 kcal\/mol. This"},{"key":"ref670","unstructured":"type of interaction can suppress the inhibitory signal"},{"key":"ref671","unstructured":"of CD300a, which can be exploited by viruses to"},{"key":"ref672","unstructured":"downregulate cellular immune activation. This finding"},{"key":"ref673","unstructured":"is supported by the hypothesis that flavonoids can"},{"key":"ref674","unstructured":"modulate the activity of immune receptors, as in the"},{"key":"ref675","unstructured":"case of the CD81 receptor, which was successfully"},{"key":"ref676","unstructured":"blocked by natural flavonoid compounds in an in silico"},{"key":"ref677","unstructured":"study with a similar interaction pattern on key aromatic"},{"key":"ref678","unstructured":"residues (Dey et al. , 2023)."},{"key":"ref679","unstructured":"IL-1\u03b2 acts as the main inflammatory cytokine that"},{"key":"ref680","unstructured":"increases during DENV infection and is responsible"},{"key":"ref681","unstructured":"for fever, pain, and vascular permeability. Docking"},{"key":"ref682","unstructured":"results show that quercetin-3-O-rutinoside occupies the"},{"key":"ref683","unstructured":"allosteric pocket of the IL-1\u03b2 protein with a binding"},{"key":"ref684","unstructured":"energy of -7.2 kcal\/mol, forming hydrogen bonds"},{"key":"ref685","unstructured":"with residues Leu178(A), Tyr184(A), Ser121(A),"},{"key":"ref686","unstructured":"and Val119(A). Hydrophobic interactions at residues"},{"key":"ref687","unstructured":"Lys208(A), Lys179(A), and Pro118(A) assist in ligand"},{"key":"ref688","unstructured":"binding to the receptor. These interactions can actively"},{"key":"ref689","unstructured":"inhibit the release of IL-1\u03b2, which is important for"},{"key":"ref690","unstructured":"suppressing cytokine storms during severe dengue"},{"key":"ref691","unstructured":"infection. This is in line with the research conducted"},{"key":"ref692","unstructured":"by Islam et al. (2025) who reported that several"},{"key":"ref693","unstructured":"natural compounds with glycoside groups can inhibit"},{"key":"ref694","unstructured":"proinflammatory cytokines by binding to their catalytic"},{"key":"ref695","unstructured":"domains (Islam et al. , 2025)."},{"key":"ref696","unstructured":"In addition to its direct antiviral role, A. purpurata"},{"key":"ref697","unstructured":"extract has the potential to strengthen the oxidative"},{"key":"ref698","unstructured":"defense system. The compounds quercetin-3-O-"},{"key":"ref699","unstructured":"rutinoside, sitosteryl-3-O-6-palmitoyl-\u03b2-D-glucoside,"},{"key":"ref700","unstructured":"and kaempferol-3-O-glucuronide were found to form"},{"key":"ref701","unstructured":"bonds on the active side of SOD that were more"},{"key":"ref702","unstructured":"stable  than the quercetin control. Therefore, natural"},{"key":"ref703","unstructured":"glycoside compounds can strengthen enzyme stability"},{"key":"ref704","unstructured":"and reduce oxidative stress in DENV infections. This"},{"key":"ref705","unstructured":"binding activity agrees with the role of flavonoids in"},{"key":"ref706","unstructured":"maintaining the stability of antioxidant metalloprotein"},{"key":"ref707","unstructured":"structures such as SOD and catalase (Pourhajibagher"},{"key":"ref708","unstructured":"and Bahador, 2024). Previous studies have reported"},{"key":"ref709","unstructured":"that glycosidic flavonoids such as quercetin-3-O-"},{"key":"ref710","unstructured":"rutinoside have a hepatoprotective effect through"},{"key":"ref711","unstructured":"increased antioxidant enzyme activity (Lozano-parra"},{"key":"ref712","unstructured":"et al., 2025). Thus, this SOD-strengthening effect may"},{"key":"ref713","unstructured":"contribute to cellular protection against virus-induced"},{"key":"ref714","unstructured":"oxidative stress."},{"key":"ref715","unstructured":"According to the results of the ADMET property"},{"key":"ref716","unstructured":"screening presented in Table 6, quercetin-3-O-rutinoside"},{"key":"ref717","unstructured":"was found to be non-mutagenic, non-hepatotoxic, non-"},{"key":"ref718","unstructured":"skin sensitizing, and did not inhibit the cardiac hERG I"},{"key":"ref719","unstructured":"channel (only hERG II). These findings are supported"},{"key":"ref720","unstructured":"by the LD\u2085\u2080 value of 1.526 mol\/kg and LOAEL value"},{"key":"ref721","unstructured":"of 2.231 log mg\/kg\/day, indicating a low acute toxicity"},{"key":"ref722","unstructured":"category (class 5), as shown in Figure 4. This safety"},{"key":"ref723","unstructured":"profile represents a major advantage compared with"},{"key":"ref724","unstructured":"some synthetic antiviral candidates that often cause"},{"key":"ref725","unstructured":"hepatotoxicity or serious cardiovascular side effects. Furthermore, the absence of hepatic toxicity indicates"},{"key":"ref726","unstructured":"that this compound is safe for long-term hepatic"},{"key":"ref727","unstructured":"metabolism. This is particularly important because the"},{"key":"ref728","unstructured":"liver is the main organ for DENV replication, and a"},{"key":"ref729","unstructured":"hepatically safe compound would minimize the risk of"},{"key":"ref730","unstructured":"systemic adverse effects. The total clearance value of"},{"key":"ref731","unstructured":"0.187 log mL\/min\/kg indicates a moderate and stable"},{"key":"ref732","unstructured":"elimination rate, which may prevent toxic accumulation"},{"key":"ref733","unstructured":"in the kidneys or other tissues. Although its distribution"},{"key":"ref734","unstructured":"volume is low (log VDss = \u22121.597), the relatively"},{"key":"ref735","unstructured":"high fraction of unbound compound ensures that it"},{"key":"ref736","unstructured":"remains bioactive in the systemic circulation and can"},{"key":"ref737","unstructured":"reach target organs such as the liver and spleen. From"},{"key":"ref738","unstructured":"a neurological perspective, some existing antiviral"},{"key":"ref739","unstructured":"agents are capable of penetrating the central nervous"},{"key":"ref740","unstructured":"system, which can result in serious neurological side"},{"key":"ref741","unstructured":"effects. In this study, the candidate compound showed"},{"key":"ref742","unstructured":"favorable BBB permeability (\u22122.215 log BB) and CNS"},{"key":"ref743","unstructured":"permeability (\u22124.842 log PS) values, indicating that it"},{"key":"ref744","unstructured":"does not cross the BBB, thereby reducing the risk of"},{"key":"ref745","unstructured":"neurotoxicity."},{"key":"ref746","unstructured":"Nevertheless, this study highlights a limitation of the"},{"key":"ref747","unstructured":"compound in terms of its low oral bioavailability,"},{"key":"ref748","unstructured":"with an intestinal absorption value of approximately"},{"key":"ref749","unstructured":"28.49% and a Caco-2 permeability of \u22120.791 log Papp."},{"key":"ref750","unstructured":"This indicates that the compound is poorly absorbed"},{"key":"ref751","unstructured":"in the gastrointestinal tract. The glycoside has a large"},{"key":"ref752","unstructured":"molecular weight (>600 Da), high polarity, and multiple"},{"key":"ref753","unstructured":"hydroxyl and sugar (rutinoside) groups, making it"},{"key":"ref754","unstructured":"highly polar and less capable of penetrating lipid"},{"key":"ref755","unstructured":"membranes. Consequently, the systemic effectiveness"},{"key":"ref756","unstructured":"of the compound when administered orally would be"},{"key":"ref757","unstructured":"limited. In addition, the compound was identified as"},{"key":"ref758","unstructured":"both a substrate and an inhibitor of P-glycoprotein,"},{"key":"ref759","unstructured":"indicating that it can be actively effluxed from intestinal"},{"key":"ref760","unstructured":"cells by transporter mechanisms, thereby reducing"},{"key":"ref761","unstructured":"the concentration of the compound that reaches the"},{"key":"ref762","unstructured":"systemic circulation."},{"key":"ref763","unstructured":"The molecular dynamics simulation section validates"},{"key":"ref764","unstructured":"the molecular docking results by evaluating the"},{"key":"ref765","unstructured":"stability of the ligand and receptor complex. The"},{"key":"ref766","unstructured":"results of the MD analysis presented in Figure 5"},{"key":"ref767","unstructured":"indicate that all compounds tend to form stable  and"},{"key":"ref768","unstructured":"well-maintained complexes. However, the complex"},{"key":"ref769","unstructured":"formed between the DC-SIGN (CD-209) protein and"},{"key":"ref770","unstructured":"the tested compound exhibited RMSF values above 3"},{"key":"ref771","unstructured":"\u00c5, indicating that complex is less stable  than the others."},{"key":"ref772","unstructured":"The high fluctuations observed in the amino acid"},{"key":"ref773","unstructured":"residues within the ligand-binding region of the DC-"},{"key":"ref774","unstructured":"SIGN receptor led to a sharp increase in RMSF values."},{"key":"ref775","unstructured":"In addition, the flexible conformation of the active"},{"key":"ref776","unstructured":"binding site and the high polarity of the compound"},{"key":"ref777","unstructured":"may have hindered the optimal penetration of the"},{"key":"ref778","unstructured":"tested ligand into the receptor\u2019s hydrophobic pocket."},{"key":"ref779","unstructured":"Huq et al. (2024)  showed that the phenolic compound"},{"key":"ref780","unstructured":"catechin from cacao, which also involves molecular"},{"key":"ref781","unstructured":"dynamics simulation, exhibits stable  bonding with the"},{"key":"ref782","unstructured":"DENV-3 RdRp enzyme, reinforcing the interpretation"},{"key":"ref783","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref784","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref785","unstructured":"3004of phenolic and biflavonoid complexes as potential"},{"key":"ref786","unstructured":"antidengue agents in this study. A study reported by"},{"key":"ref787","unstructured":"Huq et al. (2024) shows that the phenolic compound"},{"key":"ref788","unstructured":"catechin from cacao, which also involves molecular"},{"key":"ref789","unstructured":"dynamics simulation, exhibits stable  bonding with the"},{"key":"ref790","unstructured":"DENV-3 RdRp enzyme, reinforcing the interpretation"},{"key":"ref791","unstructured":"of phenolic and biflavonoid complexes in this study as"},{"key":"ref792","unstructured":"potential antidengue agents. In addition, the presence of"},{"key":"ref793","unstructured":"hydrogen, hydrophobic, and Van der Walls interactions"},{"key":"ref794","unstructured":"in this study formed a strong binding pattern on the"},{"key":"ref795","unstructured":"amino acid residues present in the body\u2019s immune"},{"key":"ref796","unstructured":"receptors, which means that it can trigger a bioactivity"},{"key":"ref797","unstructured":"response to prevent dengue from entering the cell"},{"key":"ref798","unstructured":"In conclusion, the ethanol extract of A. purpurata"},{"key":"ref799","unstructured":"shows potential antiviral activity against DENV-3 in"},{"key":"ref800","unstructured":"vitro and in silico . In vitro testing of viral replication"},{"key":"ref801","unstructured":"activity showed an EC50 value of 105.8107 \u00b5g\/mL for"},{"key":"ref802","unstructured":"the extract, compared to 92.6923 \u00b5g\/mL for the control."},{"key":"ref803","unstructured":"The natural glycoside quercetin-3-O-rutinoside was"},{"key":"ref804","unstructured":"most effective in inhibiting virus binding to DC-SIGN"},{"key":"ref805","unstructured":"receptors (\u22127.8 kcal\/mol), balancing immune signals"},{"key":"ref806","unstructured":"through CD300a receptor regulation (\u22127.1 kcal\/"},{"key":"ref807","unstructured":"mol), suppressing the production of proinflammatory"},{"key":"ref808","unstructured":"cytokine IL-1\u03b2 during a cytokine storm (\u22127.2 kcal\/"},{"key":"ref809","unstructured":"mol), and activating the endogenous antioxidant"},{"key":"ref810","unstructured":"superoxide dismutase (\u22127.0 kcal\/mol). Validation using"},{"key":"ref811","unstructured":"molecular dynamics showed that the overall quercetin-"},{"key":"ref812","unstructured":"3-O-rutinoside complex tended to be stable  with an"},{"key":"ref813","unstructured":"RMSF value < 3 \u00c5, while the DC-SIGN (CD209)"},{"key":"ref814","unstructured":"complex had an RMSF value > 3 \u00c5. ADMET and"},{"key":"ref815","unstructured":"toxicity profiling confirmed favorable pharmacokinetic"},{"key":"ref816","unstructured":"safety with non-hepatotoxic and non-mutagenic"},{"key":"ref817","unstructured":"properties. These findings highlight quercetin-3-O-"},{"key":"ref818","unstructured":"rutinoside as a promising, safe, and multitarget natural"},{"key":"ref819","unstructured":"antiviral candidate for future in vivo  and preclinical"},{"key":"ref820","unstructured":"development against dengue virus infection."},{"key":"ref821","unstructured":"Acknowledgments"},{"key":"ref822","unstructured":"The authors gratefully acknowledge financial support"},{"key":"ref823","unstructured":"from the scholarship of Program Magister Menuju"},{"key":"ref824","unstructured":"Doktor untuk Sarjana Unggul (PMDSU)."},{"key":"ref825","unstructured":"This study was supported by the Program Magister"},{"key":"ref826","unstructured":"Menuju Doktor untuk Sarjana Unggul (PMDSU)"},{"key":"ref827","unstructured":"scholarship with Decree Number 0419\/C3\/"},{"key":"ref828","unstructured":"DT.05.00\/2025 and Agreement\/Contract Number 059\/"},{"key":"ref829","unstructured":"C3\/DT.05.00\/PL\/2025 from the Ministry of Higher"},{"key":"ref830","unstructured":"Education, Research, and Technology, Republic of"},{"key":"ref831","unstructured":"Authors' contributions"},{"key":"ref832","unstructured":"Conception, design, and materials: MAH, WD, and"},{"key":"ref833","unstructured":"DW; supervision and resources: WD, DW, and THS;"},{"key":"ref834","unstructured":"data collection and literature search: MAH, RAR, RJK,"},{"key":"ref835","unstructured":"and AUR; analysis and interpretation: MAH, AUR, PAW, and FK; manuscript writing: MAH, WD, AUR,"},{"key":"ref836","unstructured":"RJK, and ER; and critical review: WD, DW, and THS."},{"key":"ref837","unstructured":"Conflict of interest"},{"key":"ref838","unstructured":"The authors declare no conflict of interest."},{"key":"ref839","unstructured":"Data availability"},{"key":"ref840","unstructured":"All data supporting this study\u2019s findings are available"},{"key":"ref841","unstructured":"within the manuscript."},{"key":"ref842","unstructured":"Abdul Ahmad, S.A., Palanisamy, U.D., Tejo, B.A.,"},{"key":"ref843","unstructured":"Chew, M.F., Tham, H.W. and Syed Hassan, S. 2017."},{"key":"ref844","unstructured":"Geraniin extracted from the rind of Nephelium"},{"key":"ref845","unstructured":"lappaceum binds to dengue virus type-2 envelope"},{"key":"ref846","unstructured":"protein and inhibits early stage of virus replication."},{"key":"ref847","doi-asserted-by":"crossref","unstructured":"Virol. J. 14(1), 229; doi:10.1186\/s12985-017-0895-1","DOI":"10.1186\/s12985-017-0895-1"},{"key":"ref848","unstructured":"Aguinaldo, A., Villaflores, O., Macabeo, A.P.,"},{"key":"ref849","unstructured":"Gehle, D., Krohn, K. and Franzblau, S. 2010."},{"key":"ref850","unstructured":"Phytoconstituents from Alpinia purpurata and their"},{"key":"ref851","unstructured":"in vitro inhibitory activity against Mycobacterium"},{"key":"ref852","unstructured":"tuberculosis. Pharmacognosy. Mag. 6(24), 339\u2013"},{"key":"ref853","unstructured":"Alagarasu, K., Patil, P., Kaushik, M., Chowdhury, D.,"},{"key":"ref854","unstructured":"Joshi, R.K., Hegde, H.V ., Kakade, M.B., Hoti, S.L.,"},{"key":"ref855","unstructured":"Cherian, S. and Parashar, D. 2022. In vitro antiviral"},{"key":"ref856","unstructured":"activity of potential medicinal plant extracts"},{"key":"ref857","unstructured":"against dengue and chikungunya viruses. Front."},{"key":"ref858","unstructured":"Cellular. InfectMicrobiol. 12, 866452; doi:10.3389\/"},{"key":"ref859","unstructured":"fcimb.2022.866452"},{"key":"ref860","unstructured":"Alam, M.M., Jarvis, C.M., Hincapie, R., Mckay, C.S.,"},{"key":"ref861","unstructured":"Schimer, J., Sanhueza, C.A., Xu, K., Diehl, R.C.,"},{"key":"ref862","unstructured":"Finn, M.G. and Kiessling, L.L. 2020. Glycan-"},{"key":"ref863","unstructured":"modified virus-like particles evoke T helper type"},{"key":"ref864","unstructured":"1-like immune responses. ACS. Nano 15(1), 309\u2013"},{"key":"ref865","doi-asserted-by":"crossref","unstructured":"321; doi: 10.1021\/acsnano.0c03023","DOI":"10.1021\/acsnano.0c03023"},{"key":"ref866","unstructured":"Alifiansyah, M.R.T., Herdiansyah, M.A., Pratiwi,"},{"key":"ref867","unstructured":"R.C., Pramesti, R.P., Hafsyah, N.W., Rania, A.P.,"},{"key":"ref868","unstructured":"Putra, J.E.R.P., Cahyono, P.A., Litazkiyyah, S.K.,"},{"key":"ref869","unstructured":"Muhammad, S.K., Murtadlo, A.A.A., Kharisma,"},{"key":"ref870","unstructured":"V .D., Ansori, A.N.M., Jakhmola, V ., Ashok, P.K.,"},{"key":"ref871","unstructured":"Kalra, J.M., Purnobasuki, H. and Pratiwi, I.A. 2024."},{"key":"ref872","unstructured":"QSAR of acyl alizarin red biocompound derivatives"},{"key":"ref873","unstructured":"of Rubia tinctorum roots and its ADMET properties"},{"key":"ref874","unstructured":"as anti-breast cancer candidates against MMP-9"},{"key":"ref875","unstructured":"protein receptor: in silico study. Food. Syst. 7, 312\u2013"},{"key":"ref876","unstructured":"320; https:\/\/doi.org\/10.1016\/"},{"key":"ref877","unstructured":"Altamish, M., Khan, M., Baig, M.S., Pathak, B., Rani,"},{"key":"ref878","unstructured":"V ., Akhtar, J., Khan, A.A., Ahmad, S. and Krishnan,"},{"key":"ref879","unstructured":"A. 2022. Therapeutic potential of medicinal plants"},{"key":"ref880","unstructured":"against dengue infection: a mechanistic viewpoint."},{"key":"ref881","unstructured":"ACS. Omega. 7(28), 24048\u201324065; doi:10.1021\/"},{"key":"ref882","unstructured":"acsomega.2c00625"},{"key":"ref883","unstructured":"Ansori, A.N.M., Fadhlolly, A., Proboningrat, A.,"},{"key":"ref884","unstructured":"Hayaza, S., Susilo, R.J.K., Naw, S.W., Posa,"},{"key":"ref885","unstructured":"G.A.V ., Yusrizal, Y .F., Sibero, M.T., Sucipto, T.H."},{"key":"ref886","unstructured":"and Seogijanto, S. 2021. In vitro antiviral activity"},{"key":"ref887","unstructured":"of Pinus merkusii (Pinaceae) stem bark and cone"},{"key":"ref888","unstructured":"against dengue virus type-2 (DENV-2). Res. J."},{"key":"ref889","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref890","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref891","unstructured":"3005Pharm. Technol. 1, 3705\u20133708; doi:10.52711\/0974-"},{"key":"ref892","unstructured":"360x.2021.00641"},{"key":"ref893","unstructured":"Aryati, A., Wrahatnala, B.J., Yohan, B., Fanny,"},{"key":"ref894","unstructured":"M., Hakim, F.K.N., Sunari, E.P., Zuroidah, N.,"},{"key":"ref895","unstructured":"Wardhani, P., Santoso, M.S., Husada, D., Rohman,"},{"key":"ref896","unstructured":"A., Tarmizi, S.N., Sievers, J.T.O. and Sasmono,"},{"key":"ref897","unstructured":"R.T. 2020. Dengue virus serotype 4 is responsible"},{"key":"ref898","unstructured":"for the outbreak of dengue in East Java City of"},{"key":"ref899","unstructured":"Jember, Indonesia. Viruses 12(9), 913; doi:10.3390\/"},{"key":"ref900","unstructured":"Banerjee, P., Kemmler, E., Dunkel, M. and Preissner, R."},{"key":"ref901","unstructured":"2024. ProTox 3.0: a webserver for the prediction of"},{"key":"ref902","unstructured":"toxicity of chemicals. Nucleic. Acids. Res. 52(W1),"},{"key":"ref903","doi-asserted-by":"crossref","unstructured":"W513\u2013W520; doi:10.1093\/nar\/gkae303","DOI":"10.1093\/nar\/gkae303"},{"key":"ref904","unstructured":"Begum, F., Das, S., Mukherjee, D. and Ray, U. 2019."},{"key":"ref905","unstructured":"Hijacking the host immune cells by dengue virus:"},{"key":"ref906","unstructured":"molecular interplay of receptors and dengue virus"},{"key":"ref907","unstructured":"envelope. Microorganisms 7(9), 323; doi:10.3390\/"},{"key":"ref908","unstructured":"microorganisms7090323"},{"key":"ref909","unstructured":"Carnec, X., Meertens, L., Dejarnac, O., Perera-Lecoin,"},{"key":"ref910","unstructured":"M., Hafirassou, M.L., Kitaura, J., Ramdasi,"},{"key":"ref911","unstructured":"R., Schwartz, O. and Amara, A. 2015. The"},{"key":"ref912","unstructured":"phosphatidylserine and phosphatidylethanolamine"},{"key":"ref913","unstructured":"receptor CD300a binds dengue virus and enhances"},{"key":"ref914","unstructured":"infection. J. Virol. 90(1), 92\u2013102; doi:10.1128\/"},{"key":"ref915","unstructured":"JVI.01849-15"},{"key":"ref916","unstructured":"Dey, D., Biswas, P., Paul, P., Mahmud, S., Ema, T.I.,"},{"key":"ref917","unstructured":"Khan, A.A., Ahmed, S.Z., Hasan, M.M., Saikat,"},{"key":"ref918","unstructured":"A.S.M., Fatema, B., Bibi, S., Rahman, M.A. and"},{"key":"ref919","unstructured":"Kim, B. 2023. Natural flavonoids effectively block"},{"key":"ref920","unstructured":"the CD81 receptor of hepatocytes and inhibit HCV"},{"key":"ref921","unstructured":"infection: a computational drug development"},{"key":"ref922","unstructured":"approach. Mol. Diversity 27(3), 1309\u20131322;"},{"key":"ref923","doi-asserted-by":"crossref","unstructured":"doi:10.1007\/s11030-022-10491-9","DOI":"10.1007\/s11030-022-10491-9"},{"key":"ref924","unstructured":"Fatima, S., Gupta, P., Sharma, S., Sharma, A. and"},{"key":"ref925","unstructured":"Agarwal, S.M. 2020. ADMET profiling of"},{"key":"ref926","unstructured":"geographically diverse phytochemical using"},{"key":"ref927","unstructured":"chemoinformatic tools. Future MedChem. 12(1),"},{"key":"ref928","doi-asserted-by":"crossref","unstructured":"69\u201387; doi:10.4155\/fmc-2019-0206","DOI":"10.4155\/fmc-2019-0206"},{"key":"ref929","unstructured":"Gbore, D.J., Zakari, S. and Yusuf, L. 2023. In silico"},{"key":"ref930","unstructured":"studies of bioactive compounds from Alpinia"},{"key":"ref931","unstructured":"officinarum as inhibitors of Zika virus protease."},{"key":"ref932","unstructured":"Unlocked Informat. Med. 38, 101214."},{"key":"ref933","unstructured":"Harapan, H., Michie, A., Yohan, B., Shu, P.Y ., Mudatsir,"},{"key":"ref934","unstructured":"M., Sasmono, R.T. and Imrie, A. 2019. Dengue"},{"key":"ref935","unstructured":"viruses circulating in Indonesia: a systematic"},{"key":"ref936","unstructured":"review and phylogenetic analysis of data from"},{"key":"ref937","unstructured":"five decades. Rev. Med. Virol. 29(4), e2037;"},{"key":"ref938","doi-asserted-by":"crossref","unstructured":"doi:10.1002\/rmv.2037","DOI":"10.1002\/rmv.2037"},{"key":"ref939","unstructured":"Herdiansyah, M.A., Rizaldy, R., Alifiansyah, M.R.,"},{"key":"ref940","unstructured":"Fetty, A.J., Anggraini, D., Agustina, N., Alfian,"},{"key":"ref941","unstructured":"F.R., Setianingsih, P.N., Elfianah, V ., Aulia, H.S.,"},{"key":"ref942","unstructured":"Putra, J.E., Ansori, A.N., Kharisma, V .D., Jakhmola,"},{"key":"ref943","unstructured":"V ., Purnobasuki, H., Pratiwi, I.A., Rebezov, M.,"},{"key":"ref944","unstructured":"Shmeleva, S., Bonkalo, T., Kovalchuk, D.F. and"},{"key":"ref945","unstructured":"Zainul, R. 2024. Molecular interaction analysis of"},{"key":"ref946","unstructured":"ferulic acid (4-hydroxy-3-methoxycinnamic acid)"},{"key":"ref947","unstructured":"as main bioactive compound from palm oil waste against MCF-7 receptors: an in silico study. Narra"},{"key":"ref948","doi-asserted-by":"crossref","unstructured":"J. 4(2), e775; doi:10.52225\/narra.v4i2.775","DOI":"10.52225\/narra.v4i2.775"},{"key":"ref949","unstructured":"Herrmann, F., Romero, M.R., Blazquez, A.G.,"},{"key":"ref950","unstructured":"Kaufmann, D., Ashour, M.L., Kahl, S., Marin,"},{"key":"ref951","unstructured":"J.J.G., Efferth, T. and Wink, M. 2011. Diversity"},{"key":"ref952","unstructured":"of pharmacological properties in Chinese and"},{"key":"ref953","unstructured":"European medicinal plants: cytotoxicity, antiviral"},{"key":"ref954","unstructured":"and antitrypanosomal screening of 82 herbal drugs."},{"key":"ref955","unstructured":"Diversity 3(4), 547\u2013580."},{"key":"ref956","unstructured":"Hsieh, T.H., Tsai, T.T., Chen, C.L., Shen, T.J., Jhan,"},{"key":"ref957","unstructured":"M.K., Tseng, P.C. and Lin, C.F. 2020. Senescence"},{"key":"ref958","unstructured":"in monocytes facilitates dengue virus infection"},{"key":"ref959","unstructured":"by increasing infectivity. Front. Cellular Infect."},{"key":"ref960","doi-asserted-by":"crossref","unstructured":"Microbiol. 10, 375; doi:10.3389\/fcimb.2020.00375","DOI":"10.3389\/fcimb.2020.00375"},{"key":"ref961","unstructured":"Huq, A.K.M.M., Roney, M., Dubey, A., Nasir, M.H.,"},{"key":"ref962","unstructured":"Tufail, A., Aluwi, M.F.F.M., Ishak, W.M.W.,"},{"key":"ref963","unstructured":"Islam, M.R. and Tajuddin, S.N. 2024. Phenolic"},{"key":"ref964","unstructured":"compounds of Theobroma cacao L. show potential"},{"key":"ref965","unstructured":"against dengue RdRp protease enzyme inhibition"},{"key":"ref966","unstructured":"by in-silico docking, DFT study, MD simulation"},{"key":"ref967","unstructured":"and MMGBSA calculation. PLoS One, 19(3),"},{"key":"ref968","doi-asserted-by":"crossref","unstructured":"e0299238; doi: 10.1371\/journal.pone.0299238","DOI":"10.1371\/journal.pone.0299238"},{"key":"ref969","unstructured":"Ichsyani, M., Ridhanya, A., Risanti, M., Desti, H.,"},{"key":"ref970","unstructured":"Ceria, R., Putri, D.H., Sudiro, T.M. and Dewi,"},{"key":"ref971","unstructured":"B.E. Antiviral effects of Curcuma longa L. against"},{"key":"ref972","unstructured":"dengue virus in vitro and in vivo. In IOP Conference"},{"key":"ref973","unstructured":"Series: Earth and Environmental Science, Bristol,"},{"key":"ref974","unstructured":"UK, IOP Publishing Ltd, 2017, vol. 101(1), p"},{"key":"ref975","doi-asserted-by":"crossref","unstructured":"012005; doi: 10.1088\/1755-1315\/101\/1\/012005","DOI":"10.1088\/1755-1315\/101\/1\/012005"},{"key":"ref976","unstructured":"Imran, M., Abida., Alotaibi, N.M., Thabet, H.K.,"},{"key":"ref977","unstructured":"Alruwaili, J.A., Eltaib, L., Alshehri, A. and Kamal,"},{"key":"ref978","unstructured":"M. 2025. Investigation of natural compounds as"},{"key":"ref979","unstructured":"methyltransferase inhibitors against dengue virus:"},{"key":"ref980","unstructured":"an in silico approach. J. Biomolecular Struct. &."},{"key":"ref981","unstructured":"Dyn. 43(11), 5577\u20135592; doi:10.1080\/07391102.2"},{"key":"ref982","unstructured":"024.2309647"},{"key":"ref983","unstructured":"Islam, M.T., Aktaruzzaman, M., Saif, A., Akter,"},{"key":"ref984","unstructured":"A., Bhat, M.A., Hossain, M.M., Alam, S.M.N.,"},{"key":"ref985","unstructured":"Rayhan, R., Rehman, S., Yaseen, M. and Raihan,"},{"key":"ref986","unstructured":"M.O. 2025. In silico-based identification of natural"},{"key":"ref987","unstructured":"inhibitors from traditionally used medicinal plants"},{"key":"ref988","unstructured":"that can inhibit dengue infection. Mol. Biotechnol."},{"key":"ref989","doi-asserted-by":"crossref","unstructured":"67, 2382\u20132398; doi:10.1007\/s12033-024-01204-8","DOI":"10.1007\/s12033-024-01204-8"},{"key":"ref990","unstructured":"Jasso-Miranda, C., Herrera-Camacho, I., Flores-"},{"key":"ref991","unstructured":"Mendoza, L.K., Dominguez, F., Vallejo-Ruiz, V .,"},{"key":"ref992","unstructured":"Sanchez-Burgos, G.G., Pando-Robles, V ., Santos-"},{"key":"ref993","unstructured":"Lopez, G. and Reyes-Leyva, J. 2019. Antiviral"},{"key":"ref994","unstructured":"and immunomodulatory effects of polyphenols on"},{"key":"ref995","unstructured":"macrophages infected with dengue virus serotypes 2"},{"key":"ref996","unstructured":"and 3 enhanced or not with antibodies. Infect. Drug"},{"key":"ref997","doi-asserted-by":"crossref","unstructured":"Res. 12, 1833\u20131852; doi:10.2147\/IDR.S210890","DOI":"10.2147\/IDR.S210890"},{"key":"ref998","unstructured":"Klimoszek, D., Jele\u0144, M., Do\u0142owy, M. and Morak-"},{"key":"ref999","unstructured":"M\u0142odawska, B. 2024. Study of the lipophilicity"},{"key":"ref1000","unstructured":"and ADMET parameters of new anticancer"},{"key":"ref1001","unstructured":"diquinothiazines with pharmacophore substituents."},{"key":"ref1002","unstructured":"Pharmaceuticals 17(6), 725; doi:10.3390\/"},{"key":"ref1003","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref1004","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref1005","unstructured":"3006Koishi, A.C., Zanello, P.R., Bianco, E.M., Bordignon, J."},{"key":"ref1006","unstructured":"and Nunes Duarte Dos Santos, C. 2012. Screening of"},{"key":"ref1007","unstructured":"Dengue virus antiviral activity of marine seaweeds"},{"key":"ref1008","unstructured":"by an in situ enzyme-linked immunosorbent assay."},{"key":"ref1009","unstructured":"PLos One 7(12), e51089; doi:10.1371\/journal."},{"key":"ref1010","unstructured":"pone.0051089"},{"key":"ref1011","unstructured":"Kong, L.Y ., Zhang, W.J. and Luo, J.G. 2016. The"},{"key":"ref1012","unstructured":"genus Alpinia: a review of its phytochemistry and"},{"key":"ref1013","unstructured":"pharmacology. World. J. Traditional. Chin. Med."},{"key":"ref1014","unstructured":"2(1), 26\u201341."},{"key":"ref1015","unstructured":"Low, Z.X., Ouyong, B.M., Hassandarvish, P., Poh,"},{"key":"ref1016","unstructured":"C.L. and Ramanathan, B. 2021. Antiviral activity"},{"key":"ref1017","unstructured":"of silymarin and baicalein against dengue virus."},{"key":"ref1018","unstructured":"Scientific. Rep. 11(1), 21221; doi:10.1038\/s41598-"},{"key":"ref1019","unstructured":"021-98949-y"},{"key":"ref1020","unstructured":"Lozano-Parra, A., Herrera, V . and Villar, L.A. 2025."},{"key":"ref1021","unstructured":"Antioxidant response as a candidate prognostic"},{"key":"ref1022","unstructured":"factor for dengue hypotensive and hemorrhagic"},{"key":"ref1023","unstructured":"complications: results from a nested case-control"},{"key":"ref1024","unstructured":"study in Colombia. Trop. Med. Infect. Dis. 10(1),"},{"key":"ref1025","doi-asserted-by":"crossref","unstructured":"14; doi:10.3390\/tropicalmed10010014","DOI":"10.3390\/tropicalmed10010014"},{"key":"ref1026","unstructured":"Mvondo, J.G.M., Matondo, A., Mawete, D.T., Bambi,"},{"key":"ref1027","unstructured":"S.M.N., Mbala, B.M. and Lohohola, P.O. 2021. In"},{"key":"ref1028","unstructured":"silico ADME\/T properties of quinine derivatives"},{"key":"ref1029","unstructured":"using SwissADME and pkCSM webservers. Int. J."},{"key":"ref1030","unstructured":"Trop. Dis. &. Health 42(i1130), 49\u201392; doi:10.9734\/"},{"key":"ref1031","unstructured":"ijtdh\/2021\/v42i1130492"},{"key":"ref1032","unstructured":"Newman, R.A., Sastry, K.J., Arav-Boger, R., Cai, H.,"},{"key":"ref1033","unstructured":"Matos, R. and Harrod, R. 2020. Antiviral effects of"},{"key":"ref1034","unstructured":"Oleandrin. J. Exp. Pharmacol. 12, 503\u2013515; doi:"},{"key":"ref1035","doi-asserted-by":"crossref","unstructured":"10.2147\/JEP.S273120","DOI":"10.2147\/JEP.S273120"},{"key":"ref1036","unstructured":"Narusaka, M., Yamaji, Y ., Uraji, M., Hatanaka, T.,"},{"key":"ref1037","unstructured":"Narusaka. and Y . 2020. Inhibitory effects of Alpinia"},{"key":"ref1038","unstructured":"zerumbet extract against plant virus infection in"},{"key":"ref1039","unstructured":"solanaceous plants. Plant Biotechnol. 37(1), 93\u201397."},{"key":"ref1040","unstructured":"Panda, K., Alagarasu, K., Patil, P., Agrawal, M.,"},{"key":"ref1041","unstructured":"More, A., Kumar, N.V ., Mainkar, P.S., Parashar,"},{"key":"ref1042","unstructured":"D. and Cherian, S. 2021. In vitro antiviral activity"},{"key":"ref1043","unstructured":"of \u03b1-mangostin against dengue virus serotype-2"},{"key":"ref1044","unstructured":"(DENV-2). Molecules. (Basel. Switzerland)."},{"key":"ref1045","doi-asserted-by":"crossref","unstructured":"26(10), 3016; doi:10.3390\/molecules26103016","DOI":"10.3390\/molecules26103016"},{"key":"ref1046","unstructured":"Pourhajibagher, M. and Bahador, A. 2024."},{"key":"ref1047","unstructured":"Bioinformatics analysis of photoexcited natural"},{"key":"ref1048","unstructured":"flavonoid glycosides as the inhibitors for"},{"key":"ref1049","unstructured":"oropharyngeal HPV oncoproteins. AMB. Express."},{"key":"ref1050","doi-asserted-by":"crossref","unstructured":"14(1), 29; doi:10.1186\/s13568-024-01684-6","DOI":"10.1186\/s13568-024-01684-6"},{"key":"ref1051","unstructured":"Ramalingam, S., Karupannan, S., Padmanaban, P.,"},{"key":"ref1052","unstructured":"Vijayan, S., Sheriff, K., Palani, G. and Krishnasamy,"},{"key":"ref1053","unstructured":"K.K. 2018. Anti-dengue activity of Andrographis"},{"key":"ref1054","unstructured":"paniculata extracts and quantification of dengue"},{"key":"ref1055","unstructured":"viral inhibition by SYBR green reverse transcription"},{"key":"ref1056","unstructured":"polymerase chain reaction. Ayu 39(2), 87\u201391."},{"key":"ref1057","unstructured":"Rosmalena, R., Elya, B., Dewi, B.E., Fithriyah, F.,"},{"key":"ref1058","unstructured":"Desti, H., Angelina, M., Hanafi, M., Lotulung,"},{"key":"ref1059","unstructured":"P.D., Prasasty, V .D. and Seto, D. 2019. The antiviral"},{"key":"ref1060","unstructured":"effect of indonesian medicinal plant extracts against"},{"key":"ref1061","unstructured":"dengue virus in vitro and in silico. Pathogens (Basel. Switzerland). 8(2), 85; doi:10.3390\/"},{"key":"ref1062","unstructured":"pathogens8020085"},{"key":"ref1063","unstructured":"Sari, A.V ., Aryati.., Budhy, T.I., Ma\u2019ruf, A., Husada, D.,"},{"key":"ref1064","unstructured":"Palupi, P., Sunari, I.G.A.A.E.P. and Indrasari, Y .N."},{"key":"ref1065","unstructured":"2025. Correlation between IL-1\u03b2 and IL-18 levels"},{"key":"ref1066","unstructured":"with the severity of dengue infection. Indonesian. J."},{"key":"ref1067","unstructured":"Clin. Pathol. Med. Lab. 31(3), 286\u2013291."},{"key":"ref1068","unstructured":"Shivanika S Deepak., Kumar V Ragunathan., Tiwari"},{"key":"ref1069","unstructured":"A Sumitha. and Devi, B. 2022. Molecular"},{"key":"ref1070","unstructured":"docking, validation, dynamics simulations, and"},{"key":"ref1071","unstructured":"pharmacokinetic prediction of natural compounds"},{"key":"ref1072","unstructured":"against the SARS-CoV-2 main-protease. J. Biomol."},{"key":"ref1073","unstructured":"Struct. Dyn. 40, 585\u2013611."},{"key":"ref1074","unstructured":"Shobahah, J., Wahyuningsih, S., Winarni, D.,"},{"key":"ref1075","unstructured":"Herdiansyah, M. and Aly, M. 2025. In silico"},{"key":"ref1076","unstructured":"evaluation of vitamin D3 as a dual inhibitor of"},{"key":"ref1077","unstructured":"CDK2 and Bcl-2 in colorectal cancer. Open. Vet. J."},{"key":"ref1078","unstructured":"15(8), 3759; doi:10.1016\/j.ovj.2025.03759"},{"key":"ref1079","unstructured":"Singh, S., Almuhanna, Y ., Alshahrani, M.Y ., Lowman,"},{"key":"ref1080","unstructured":"D.W., Rice, P.J., Gell, C., Ma, Z., Graves, B.,"},{"key":"ref1081","unstructured":"Jackson, D., Lee, K., Juarez, R., Koranteng, J.,"},{"key":"ref1082","unstructured":"Muntaka, S., Daniel A. Mitchell., Da Silva, A.C.,"},{"key":"ref1083","unstructured":"Hussain, F., Yilmaz, G., Mastrotto, F., Irie, Y .,"},{"key":"ref1084","unstructured":"Williams, P., Williams, D.L., C\u00e1mara, M. and"},{"key":"ref1085","unstructured":"Martinez-Pomares, L. 2021. Carbohydrates from"},{"key":"ref1086","unstructured":"Pseudomonas aeruginosa biofilms interact with"},{"key":"ref1087","unstructured":"immune C-type lectins and interfere with their"},{"key":"ref1088","unstructured":"receptor function. NPJ. Biofilms. Microbiomes."},{"key":"ref1089","doi-asserted-by":"crossref","unstructured":"7(1), 87; doi:10.1038\/s41522-021-00257-w","DOI":"10.1038\/s41522-021-00257-w"},{"key":"ref1090","unstructured":"Siti Rahayu., Aulia Umi Rohmatika., Ufairanisa"},{"key":"ref1091","unstructured":"Islamatasya., Mochammad Aqilah Herdiansyah.,"},{"key":"ref1092","unstructured":"Raden Joko Kuncoroningrat Susilo., Suhailah"},{"key":"ref1093","unstructured":"Hayaza., Djoko Santoso., Odi Yoshitaka Anggarda.,"},{"key":"ref1094","unstructured":"Sri Puji Astuti Wahyuningsih. and Win Darmanto."},{"key":"ref1095","unstructured":"2025. Potential of Ganoderma applanatum"},{"key":"ref1096","unstructured":"extract as anticancer and immunomodulator in"},{"key":"ref1097","unstructured":"diethylnitrosamine-induced colon cancer. Trop. J."},{"key":"ref1098","unstructured":"Natural. Product. Res. 9(9), 4310\u20134320."},{"key":"ref1099","unstructured":"Soe, A.M., Ngwe Tun, M.M., Nabeshima, T., Myat,"},{"key":"ref1100","unstructured":"T.W., Htun, M.M., Lin, H., Hom, N.S., Inoue, S.,"},{"key":"ref1101","unstructured":"Nwe, K.M., Aye, L.P.P., Fukuta, M., Thant, K.Z.,"},{"key":"ref1102","unstructured":"Hasebe, F., Morita, K., Shresta, S., Thu, H.M. and"},{"key":"ref1103","unstructured":"Moi, M.L. 2021. Emergence of a novel dengue virus"},{"key":"ref1104","unstructured":"3 (DENV-3) genotype-i coincident with increased"},{"key":"ref1105","unstructured":"DENV-3 cases in Yangon, Myanmar between"},{"key":"ref1106","unstructured":"2017 and 2019. Viruses 13(6), 1152; doi:10.3390\/"},{"key":"ref1107","unstructured":"Sucipto, T.H., Churrotin, S., Setyawati, H., Kotaki,"},{"key":"ref1108","unstructured":"T., Martak, F. and Soegijanto, S. 2017. Antiviral"},{"key":"ref1109","unstructured":"activity of copper(ii)chloride dihydrate againsts"},{"key":"ref1110","unstructured":"dengue virus type-2 in vero cell. Indonesian J."},{"key":"ref1111","unstructured":"Trop. Infect. Dis. 6(4), 84\u201387; doi:10.1016\/j."},{"key":"ref1112","doi-asserted-by":"crossref","unstructured":"ijtd.2017.01.002","DOI":"10.1088\/1475-7516\/2017\/01\/002"},{"key":"ref1113","unstructured":"Suzery, M., Ningrum, A.N., Nudin, B., Mulyani, N.S. and"},{"key":"ref1114","unstructured":"Cahyono, B. 2019. Determination of quercetin and"},{"key":"ref1115","unstructured":"rutin in red galangal rhizomes (Alpinia purpurata)"},{"key":"ref1116","unstructured":"and white galangal (Alpinia galanga) with high"},{"key":"ref1117","unstructured":"performance liquid chromatography method. In"},{"key":"ref1118","unstructured":"http:\/\/www.openveterinaryjournal.com"},{"key":"ref1119","doi-asserted-by":"crossref","unstructured":"M. A. Herdiansyah et al.  Open Veterinary Journal , (2026), V ol. 16(5): 2987-3007","DOI":"10.5455\/OVJ.2026.v16.i5.42"},{"key":"ref1120","unstructured":"3007IOP Conference Series: Earth and Environmental"},{"key":"ref1121","unstructured":"Science, Bristol, UK, IOP Publishing Ltd, 2019, vol."},{"key":"ref1122","unstructured":"292(1), pp 12\u201364; doi:10.1016\/j.iosc.2018.01.006"},{"key":"ref1123","unstructured":"Tanaka, J., Gleinich, A.S., Zhang, Q., Whitfield, R.,"},{"key":"ref1124","unstructured":"Kempe, K., Haddleton, D.M., Davis, T.P., Perrier,"},{"key":"ref1125","unstructured":"S., Mitchell, D.A. and Wilson, P. 2017. Specific"},{"key":"ref1126","unstructured":"and differential binding of N-acetylgalactosamine"},{"key":"ref1127","unstructured":"glycopolymers to the human macrophage"},{"key":"ref1128","unstructured":"galactose lectin and asialoglycoprotein receptor."},{"key":"ref1129","unstructured":"Biomacromolecules 18(5), 1624\u20131633;"},{"key":"ref1130","doi-asserted-by":"crossref","unstructured":"doi:10.1021\/acs.biomac.7b00228","DOI":"10.1021\/acs.biomac.7b00228"},{"key":"ref1131","unstructured":"Titir, S.R., Paul, S.K., Ahmed, S., Haque, N., Nasreen,"},{"key":"ref1132","unstructured":"S.A., Hossain, K.S., Ahmad, F.U., Nila, S.S.,"},{"key":"ref1133","unstructured":"Khanam, J., Nowsher, N., Al Amin, A.M.M.,"},{"key":"ref1134","unstructured":"Khan, A.U., Aung, M.S. and Kobayashi, N."},{"key":"ref1135","unstructured":"2021. Nationwide distribution of dengue virus"},{"key":"ref1136","unstructured":"type 3 (DENV-3) genotype i and emergence of"},{"key":"ref1137","unstructured":"DENV-3 genotype iii during the 2019 outbreak"},{"key":"ref1138","unstructured":"in Bangladesh. Trop. Med. Infect. Dis. 6(2), 58;"},{"key":"ref1139","doi-asserted-by":"crossref","unstructured":"doi:10.3390\/tropicalmed6020058","DOI":"10.3390\/tropicalmed6020058"},{"key":"ref1140","unstructured":"Utama, I.M.S., Lukman, N., Sukmawati, D.D.,"},{"key":"ref1141","unstructured":"Alisjahbana, B., Alam, A., Murniati, D., Utama,"},{"key":"ref1142","unstructured":"I.M.G.D.L., Puspitasari, D., Kosasih, H., Laksono,"},{"key":"ref1143","unstructured":"I., Karyana, M., Karyanti, M.R., Hapsari,"},{"key":"ref1144","unstructured":"M.M.D.E.A.H., Meutia, N., Liang, C.J., Wulan,"},{"key":"ref1145","unstructured":"W.N., Lau, C.Y . and Parwati, K.T.M. 2019."},{"key":"ref1146","unstructured":"Dengue viral infection in Indonesia: epidemiology,"},{"key":"ref1147","unstructured":"diagnostic challenges, and mutations from an"},{"key":"ref1148","unstructured":"observational cohort study. PLos One 13(10), 7785;"},{"key":"ref1149","doi-asserted-by":"crossref","unstructured":"doi:10.1371\/journal.pntd.0007785","DOI":"10.1371\/journal.pntd.0007785"},{"key":"ref1150","unstructured":"Utari, D., Hayati, A., Winarni, D., Permatasari,"},{"key":"ref1151","unstructured":"I., Fadila, H.A., Qatrunada, N., Rosida, R.,"},{"key":"ref1152","unstructured":"Afifudin, A.F.M., Pramudya, M., Muchtaromah,"},{"key":"ref1153","unstructured":"B. and Herdiansyah, M.A. 2025. Biochemical,"},{"key":"ref1154","unstructured":"histological and molecular docking into the impact"},{"key":"ref1155","unstructured":"of polystyrene nanoplastics on antioxidant enzymes"},{"key":"ref1156","unstructured":"and testicular health in rats. J. Anim. Health Prod."},{"key":"ref1157","unstructured":"13(3), 729\u2013737."},{"key":"ref1158","unstructured":"Velandia, S.A., Stashenko, E.E., Quintero-Rueda, E.,"},{"key":"ref1159","unstructured":"Conde-Ocazionez, S., Sierra, L.J. and Ocazionez,"},{"key":"ref1160","unstructured":"R.E. 2025. In vitro and in silico analyses explore the"},{"key":"ref1161","unstructured":"role of flavonoid classes in the antiviral activity of plant extracts against the dengue virus. Molecules"},{"key":"ref1162","unstructured":"30(23), 4566."},{"key":"ref1163","unstructured":"Vict\u00f3rio, C.P., Kuster, R.M. and Lage, C.L.S. 2019."},{"key":"ref1164","unstructured":"Production of rutin and kaempferol-3-o-glucuronide"},{"key":"ref1165","unstructured":"by tissue cultures of Alpinia purpurata (Vieill) K."},{"key":"ref1166","unstructured":"Schum. Latin. Am. J. Pharm. 28(4), 613\u2013616."},{"key":"ref1167","unstructured":"Villaflores, O.B., Macabeo, A.P., Gehle, D., Krohn,"},{"key":"ref1168","unstructured":"K., Franzblau, S.G. and Aguinaldo, A.M. 2010."},{"key":"ref1169","unstructured":"Phytoconstituents from Alpinia purpurata and their"},{"key":"ref1170","unstructured":"in vitro inhibitory activity against Mycobacterium"},{"key":"ref1171","unstructured":"tuberculosis. Pharmacognosy Magazine 6(24),"},{"key":"ref1172","doi-asserted-by":"crossref","unstructured":"339\u2013344; doi: 10.4103\/0973-1296.71785","DOI":"10.4103\/0973-1296.71785"},{"key":"ref1173","unstructured":"V ora, J., Patel, S., Athar, M., Sinha, S., Chhabria, M.T.,"},{"key":"ref1174","unstructured":"Jha, P.C. and Shrivastava, N. 2020. Pharmacophore"},{"key":"ref1175","unstructured":"modeling, molecular docking and molecular"},{"key":"ref1176","unstructured":"dynamics simulation for screening and identifying"},{"key":"ref1177","unstructured":"anti-dengue phytocompounds. J. Biomolecular"},{"key":"ref1178","unstructured":"Struct. Dyn. 38(6), 1726\u20131740; doi:10.1080\/0739"},{"key":"ref1179","unstructured":"1102.2019.1615002"},{"key":"ref1180","unstructured":"Warfield, K.L., Plummer, E.M., Sayce, A.C., Alonzi,"},{"key":"ref1181","unstructured":"D.S., Tang, W., Tyrrell, B.E., Hill, M.L., Caputo,"},{"key":"ref1182","unstructured":"A.T., Killingbeck, S.S., Beatty, P.R., Harris, E.,"},{"key":"ref1183","unstructured":"Iwaki, R., Kinami, K., Ide, D., Kiappes, J.L., Kato,"},{"key":"ref1184","unstructured":"A., Buck, M.D., King, K., Eddy, W., Khaliq, M.,"},{"key":"ref1185","unstructured":"Sampath, A., Treston, A.M., Dwek, R.A., Enterlein,"},{"key":"ref1186","unstructured":"S.G., Miller, J.L., Zitzmann, N., Ramstedt, U."},{"key":"ref1187","unstructured":"and Shresta, S. 2016. Inhibition of endoplasmic"},{"key":"ref1188","unstructured":"reticulum glucosidases is required for in vitro and"},{"key":"ref1189","unstructured":"in vivo dengue antiviral activity by the iminosugar"},{"key":"ref1190","unstructured":"UV-4. Antiviral. Res. 129, 93\u201398; doi:10.1016\/j."},{"key":"ref1191","doi-asserted-by":"crossref","unstructured":"antiviral.2016.03.001","DOI":"10.1016\/S2213-6320(16)30016-1"},{"key":"ref1192","unstructured":"Xue, Y ., Li, Q., Park, C.G., Klena, J.D., Anisimov, A.P.,"},{"key":"ref1193","unstructured":"Sun, Z., Wei, X. and Chen, T. 2021. Proteus mirabilis"},{"key":"ref1194","unstructured":"targets atherosclerosis plaques in human coronary"},{"key":"ref1195","unstructured":"arteries via DC-SIGN (CD209). Front. Immunol."},{"key":"ref1196","doi-asserted-by":"crossref","unstructured":"11, 579010; doi:10.3389\/fimmu.2020.579010","DOI":"10.3389\/fimmu.2020.579010"},{"key":"ref1197","unstructured":"Zhang, Z., Li, Y ., Loh, Y .R., Phoo, W.W., Hung, A.W.,"},{"key":"ref1198","unstructured":"Kang, C. and Luo, D. 2016. Crystal structure of"},{"key":"ref1199","unstructured":"unlinked NS2B-NS3 protease from Zika virus."},{"key":"ref1200","doi-asserted-by":"crossref","unstructured":"Science 354, 1597\u20131600; doi: 10.1126\/science.","DOI":"10.1126\/science"}],"container-title":["Open Veterinary Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.bibliomed.org\/fulltextpdf.php?mno=304967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:40:45Z","timestamp":1792042845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.openveterinaryjournal.com\/?mno=304967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":1200,"URL":"https:\/\/doi.org\/10.5455\/ovj.2026.v16.i5.42","relation":{},"ISSN":["2226-4485"],"issn-type":[{"value":"2226-4485","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}